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SUMMARY
The effects of antioxidants and the anthelmintics mebendazole and levamisole upon the 
asexually multiplying invasive larval stage (tetrathyridium) of Mesocestoides corti in the 
mouse were studied. In particular, the effects on larval multiplication and the possible ex­
istence of synergy against the parasite were investigated. Some histological studies were 
also undertaken to investigate more closely drug action in the mouse liver. Rates of multi­
plication of the larvae were studied in different inbred and outbred strains of mice. The 
effects of the above anthelmintics and antioxidants were also studied in Nematospiroides- 
mouse model.
Tetrathyridia, when injected into peritoneal cavities of mice, undergo rapid multiplica­
tion in the peritoneal cavities and liver. Drug efficacy was assessed by inoculating mice 
with larvae and applying a range of drug treatments before killing the mice and estimating 
the parasite burden. Mice were also infected with a fixed number of third stage larvae of 
Nematospiroides dubius and treated similarly after fourteen days of infection.
Rapid multiplication of tetrathyridia was observed in both inbred and outbred strains 
of mice. CBA male mice were found to be highly susceptible to M.corti infection, followed 
by Swiss White mice. A lower rate of proliferation of tetrathyridia was observed in Quack- 
enbush and C57 males. Sex differences in the rate of multiplication of the larvae were sig­
nificant only in parasites from the livers, there was a reduced parasite burden in females.
Administration of antioxidants and levamisole increased the rate of multiplication of 
tetrathyridia, irrespective of strain and sex of mice used. No synergistic or additive effect 
was observed between antioxidants and levamisole. Vitamin E in combination with BHA
xi x
exhibits an additive effect in increasing the larval numbers significantly from their single 
treatments. A similar effect was not observed when DPPD was combined with vitamin E. 
Levamisole and antioxidant treatment had no significant effect on the nematode, 
Nematospiroides dubius.
Oral administration of mebendazole at a dose rate of 50 mg/kg feed for five days was 
effective in removing more than 50% of the larvae from the initial inoculation, whereas a 
dose rate of 100mg/kg feed was essential in achieving similar effect on Nematospiroides 
dubius.
Vitamin E and synthetic antioxidants have no synergistic effect when combined with 
mebendazole. Infact, Mebendazole, when combined with synthetic antioxidants, displayed a 
reduced anthelmintic effect. A similar effect was observed in Nematospiroides dubius.
The synergy between mebendazole and levamisole was observed to vary according to 
the strain of mice used. A synergistic effect was observed only in QB male mice.
CHAPTER - 1
Combination Treatment in Helminth Infections
Intestinal helminthiasis, caused by the invasion of humans and animals by nematodes, 
cestodes and trematodes, is common in many countries. Helminth infections may interfere 
with human health by several mechanisms; (1) by their location - they may occupy space or 
lead to obstruction of host tissues, (2) by their number and (3) by the reactions which they 
may induce in the host. In the last few years several investigators (Blumenthal and Schultz, 
1976; Mahalanabis, Jalan, Maitra and Agarwal, 1976; Stephenson, 1980) have provided 
evidence that even light infections that are asymptomatic may be detrimental to the state 
of health of the host, particularly regarding the absorption of nutrients, growth and resis­
tance to infections. World wastage of livestock products due to parasitic disease was es­
timated at $6 billion annually, mainly as reduced fertility and growth rates, lowered wool, 
fiber and leather production and decreased milk and meat production. (Kelly and Hall, 
1979).
Various control measures have been developed including (1) grazing and pasture 
management, (2) nutritional supplement, (3) vaccination of the host and (4) chemotherapy, 
of which the last has emerged as the most effective means of control of helminthiasis to 
date.
The history of modern ruminant anthelmintics dates from 1920s. In the early twenties, 
carbon-tetrachloride was introduced with high efficacy against nematodes and trematodes. 
The first broad spectrum anthelmintic, phenothiazine, was discovered in 1930s, and or- 
ganophosphorus anthelmintics appeared during the late 1950s along with compounds of 
bephenium type. The first of the benzimidazole anthelmintics was thiabendazole, with a 
broad spectrum of activity, high efficacy and safety. It has been in use since 1961, and was 
followed by many other benzimidazole derivatives. The widespread use and misuse of an-
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thelmintics has led to drug tolerance in parasites and the emergence of drug-resistant 
strains of important parasitic helminths.
Combination therapy, the use of two or more drugs at the same time, has been con­
sidered as a more practical way of preventing the drug resistance. Various drug combina­
tions were studied and found to be highly successful for individual and mass treatment of 
polyparasitism. The main aim of combination therapy may be one or more of the following.
(1) To increase the spectrum of efficacy of chemotherapeutic response due to additive 
(drug indifference), supra-additive (synergism) or subadditive (antagonism) effects of the 
combinations. An example of a synergistic mixture is penicillin plus streptomycin for the 
treatment of endocarditis due to Streptococcus faecalis.
(2) To overcome the problem of resistance. For example, co-administration of parben- 
dazole at a reduced dose rate with oxfendazole causes increased peripheral plasma con­
centration of oxfendazole and efficacy against benzimidazole resistant nematodes. This ef­
fect is believed to be due to a temporary interference by parbendazole with microtubule as­
sembly in the liver cell, reflected as a transient reduction in bile flow rate, and thus delay­
ing the removal of oxfendazole (Hennessy, 1985).
(3) To decrease the toxicity of a drug by using its lower doses in combination with 
other drugs. A good example of this class is the equal mixture of three sulphapyrimidines 
in treatment of malaria.
(4) To achieve a broader spectrum of activity for use in multiple infections. A control 
scheme for sheep, termed "wormkiir, the strategic use of closantel and a broad-spectrum 
drug, has been developed by Dash (1985), against the infections of H.contortus and 
T.colubriformis.
(5) To antagonise the side effects of various drugs by a proper combination with other
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drugs. The side effects of a number of drugs may be reduced by using them with an an­
tagonist which competes with the drug receptor responsible for such side effects.
(6) To attack the disease process at different sites. A number of different diseases are 
associated with the functions of different body organs, hence care must be taken to attend 
to all such functions simultaneously. For example, in duodenal ulcer, a psychic factor ap­
pears to play an important role in modulating gastric secretion, hence a combination of 
antacids sedatives and ganglionic blockers are more effective. (Agarwal & Sharma, 1985).
(7) Susceptibility to drug action differs according to the life cycle forms of the 
parasites. No single drug is highly effective against all forms even of the same species. In 
filariasis, levamisole was ineffective against the microfilariae and adult worms, whereas 
mebendazole caused microfilarial migration and was only feebly microfilaricidal. The 
com bination of levamisole and mebendazole showed marked m icrofilaricidal and 
embryotoxic effects. (Awardzi, Schulz-Key, Howells, Haddock and Gills, 1982).
The combination treatments used against intestinal helminths are presented in the ap­
pendix (Table 1.1, 1.2, 1.3, 1.4, 1.5, 1.6 and 1.7) in man, sheep, horses, dogs and poultry.
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CHAPTER - 2 : INTRODUCTION
2.1 Mesocestoldes Corti
2.1.1 General
Mesocestoides sp p . are widespread in the intestines of carnivores, including man, 
throughout most of the world. (Wardle & Mcleod, 1952; Yamaguti,1959; Gleason and Healy, 
1967). Mesocestoides corti is a North American cestode of the order Cyclophillidea, first 
described by Hoeppli in 1925. To complete the life cycle, two intermediate hosts are 
required. Oribatid mites are considered to act as the first intermediate host (Soldatowa, 
1944; Anantaraman, 1954). In the body cavity and viscera of the second intermediate host, 
which may be one of a variety of amphibians, reptiles, birds or mammals, a cysticercoid 
type of second invasive larval stage, the tetrathyridium  develops. The ingested 
tetrathyridia develop in the intestine of carnivores such as skunks and dogs to become 
adult tape worms (Eckert, Van Brand and Voge, 1969).
Tetrathyridia were originally isolated from the liver and body cavity of the fence 
lizard» Sceloporus occidentalis biseriatus by Specht and Voge (1965) and were maintained 
by serial passage in the mice. When tetrathyridia were injected into rodents, multiplication 
occurred in the rat but not so extensively as in the mouse, while no infection was estab­
lished in the guinea pig. (Specht and Voge, 1965). The ease of maintainance and the rapid 
rate of multiplication of Mesocestoides corti in mice favour the use of this parasite as a 
valuable laboratory model for research.
2.1.2 Asexual multiplication of tetrathyridia of M. corti
Tetrathyridia can vary from less than 0.5 mm to over 10 mm. in length depending on 
the host and intensity and duration of infection. Each one has a scolex with four suckers 
and a single bladder (Novak, 1972). It is an unusual larval cestode that undergoes asexual
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multiplication in the definitive host in either of two ways, either by developing new pairs 
of suckers, followed by longitudinal fission, resulting in two or more individuals or by 
lateral outgrowths or buds of the body posterior to the scolex which later generate scolices. 
Hart (1968) reported the formation of acephalic forms and confirmed that these are not 
capable of reproduction. Novak (1972) also reported that tetrathyridia divide by fission of 
the body, starting at the scolex, which leaves a stumplike excretory bladder on the 
proliferative side of the organism at the end of the division. Repeated divisions leave a 
number of such bladders which may bud off acephalic fragments but Novak (1972) was 
unable to observe that these buds developed into daughter individuals. Thus the following 
three basic types of tetrathyridial bodies can be found in the host.
1. Single non-dividing larvae
2. Dividing forms and
3. Sterile acephalic forms.
Tetrathyridia kept at a temperature 3-5’c for several months with no change of medium 
remain infective (Mueller, 1972). For asexual multiplication of the tetrathyridia to occur in 
vitro at a comparable rate with that in the mouse host, a biphasic medium is required con­
taining whole human blood (Voge and Coulombe, 1966). Sexually mature, strobilated adults 
of M.corti were also grown from undifferentiated tetrathyridia in vitro using conventional 
biphasic culture systemsby Thompson, Sue and Buckley, (1982) and Barrett, Smyth and Ong, 
(1982).
2.1.3 Route of infection of M.corti larvae in mice
In mice, tetrathyridia penetrate the samll intestine and migrate to the liver from the 
peritoneal cavity at random. Due to the disruption of blood supply to large areas of paren­
chyma, the parasitic burrows become filled with erythrocytes and neutrophils. At 7-9 days 
the inflammatory response increases and erythrocyte destruction sets in. Collagen deposi­
tion sets in at 13 days post infection and fibroblasts, neutrophils and macrophages cause
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massive tissue necrosis and fibrosis. The hepatic parenchymal destruction and fibrosis al­
ters the liver as a parasite substrate, restricting the movement of the parasite. Lymphatic 
obstruction in the portal areas facilitates the entry of additional nutrients into the
COe\ovm
peritoneal cavity which is followed by parasite migration back into the gat eavk y at about 
28 days (Specht & Widmer,1972). Parenchymal regeneration then occurs within the liver, 
with the formation of concentrically layered host capsules encapsulating tetrathyridia. 
These changes confine a large number of parasites in the peritoneal cavity which multiply 
into several thousand tetrathyridia finally killing the mouse after 1.5 to 2 years (Mueller, 
1972).
The rat is a less permissive host for M.corti than the mouse (Specht & Voge,1965) but 
the course of infection is similar in both hosts ( Barton, Washington, Stewart & 
Nicholas, 1983). In rats, M.corti not only invades the liver, but the pancreas as well. In addi­
tion to the pancreatic infiltration, the parasites cause a hyperplasia of the pancreatic con­
nective tissue (Chernin and Mclaren, 1983). Hess (1972) and Conn and Etges (1983) have 
also demonstrated the transmission of M.corti from mother to young mice via the mammary 
glands. In male mice tetrathyridia were found within the scrotum (Todd, Simon and 
Dipietro, 1978). Carol and Conn (1985) have also reported the localization of tetrathyridia 
in mammary glands in pregnant mice.
2.1.4 Metabolism of M.corti larvae
Parasites are metabolic opportunists (Bryant, 1970), a view which is supported by the 
available evidence that every species of cestode examined so far consumes oxygen when 
available. (Van Brand, 1966; Prichard and Schofield, 1968a,b; De Zoeten and Tipker 1969; 
Kohler and Hamselman, 1974). Though cestodes are generally regarded as organisms with a 
predominantly anaerobic metabolism, variable amounts of oxygen exist in the natural en­
vironment of M.corti. as they live and multiply in the peritoneal cavity, lungs, liver and 
scrotum of mice. Voge and Coulombe (1966) demonstrated that tetrathyridia of M.corti 
multiplied better in cultures containing air than in cultures from which this gas was
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omitted. Weinbach and Eckert (1969) suggested that there is evidence in tetrathyridia for 
the occurrence of a mitochondrial electron transport system similar to that found in the 
higher animals. Weinbach & Eckert (1969) could not find significant differences in the 
respiration of M.corti in oxygen tensions ranging from 100 to 5 %. At 2 % or less, the rate 
of respiration was reduced, but the parasite still remained mobile. The presence of small 
amounts of oxygen in the peritoneal cavity of mice (Von Brand, 1952) suggests that these 
parasites can utilize oxygen even at the low tensions present in their natural environment 
(Weinbach and Eckert, 1969).
Tetrathyridia of M.corti are capable of consuming glucose and of excreting significant 
quantities of organic metabolic end products during in vitro incubation (Kohler and Han­
selmann, 1974). These authors found that tetrathyridia consumed considerable amounts of 
glucose both anaerobically and aerobically and produced lactate, succinate, acetate and 
carbon dioxide as major carbon containing end-products. The amount of carbon dioxide 
released as a metabolic end product is very low, which suggests that the requisite cellular 
energy supply is provided by metabolic processes functioning w ithout oxygen. 
Tetrathyridia have also been found to survive anaerobically for long periods of time 
without loss of motility (Weinbach and Eckert, 1969). The anaerobic end products in 
tetrathyridia are succinate and lactate. But in air, succinate and carbon dioxide produc­
tion fell, while lactate and acetate production remained constant. This produced a disequi­
librium in redox which has yet to be resolved. High sensitivity of larvae to cyanide may 
imply that aerobically cytochrome-Oa coupling replaces the anaerobically functioning suc­
cinate dehydrogenase-fumarate system (Weinbach & Eckert, 1969). Aerobiosis probably 
would generate ATP to a greater extent than would anaerobiosis, causing reduced succinate 
and increased fumarate levels. The metabolism of tetrathyridia thus appears to be adapted 
to both aerobic and anaerobic modes of life which is in line with the general metabolic 
pattern common to many parasitic helminths.
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2.1.5 Factors affecting M.corti
The rate of multiplication of tetrathyridia is influenced by the sex (Novak, 1972; 
Novak and Lubinsky, 1973) sex hormones (Novak, 1974) and strain of the host (White, 
Thompson & Penhale, 1982). Novak (1972) and Novak and Lubinsky (1973) showed that 
tetrathyridia of M.corti multiply faster in males than in female mice; further investigations 
by Novak in 1974 showed that sex hormones, when administered to mice infected with 
M .corti. accelarate larval m ultiplication. Testosterone increased the volume of 
intraperitoneal larvae, while oestradiol caused an increase in the number of tetrathyridia 
in the liver (Novak, 1974). Orchidectomy is more effective in depressing volumes of 
intraperitoneal populations than ovariectomy (Novak, 1975). Both testosterone and 
oestradiol increased the size of tetrathyridial populations in gonadectomized males more 
than in gonadectomized females in short term infections (up to 50 days) (Novak, 1975). The 
increase in the population was negatively correlated with the average size of the larvae and 
percentage of larvae with 4 suckers. Gonadectomy inhibits the separation of daughter 
tetrathyridia from the parental body resulting in the formation of polycephalic forms in 
long term infections (Novak, 1977). Cortisone treatment also increases the larval population 
in male and female mice, probably by suppressing immunity and (or) with direct effect on 
the parasite (Novak, 1975). But the effects of splenectomy and cortisone suggest that cell 
mediated immunity is involved in suppressing the multiplication of tetrathyridia, at least 
to some extent.
A uniform susceptibility of inbred strains of mice to M.corti infection was observed with 
the single exception of C57 BL/6 mice. (White et al.. 1982). Varying the route of inoculation 
also affected the resultant parasite burdens in certain strains but not in others (White et al.. 
1982). Thus, the rate of asexual multiplication of tetrathyridia of M.corti depends on the 
species and strain of the host, the age, sex and other physiological processes. The rate of 
multiplication in turn controls the size of the larval population and the percentage of 
polycephalic and acephalic organisms.
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2.1.6 Immunity to M.corti larvae:
Immunity to M. corti larvae can be passively transferred by serum from infected mice 
(Kowalski and Thorson, 1972a). Mice which received an injection of serum from other mice 
infected for two to three months revealed greatly reduced numbers of larvae at the time of 
autopsy compared with controls (Kowalski and Thorson, 1972a). Immunization with ex­
cretory and secretory antigen is more effective in reducing the reproductive rate of 
tetrathyridia of M.corti than is immunization with somatic antigen (Kowalski and Thorson, 
1972b). These results suggest that the mechanism of acquired resistance of the host to the 
parasite is an antigen-antibody reaction involving secretory and excretory products.
Novak (1974) reported that the removal of the spleen accelerated both the growth and 
multiplication of tetrathyr^idial populations. Pollacco (1975) established that mice can be 
immunized against a second infection with tetrathyridia by either treating primarily in­
fected mice with the anthelmintic mebendazole or by irradiating the tetrathyridia with x- 
rays. Hypothymic mice infected with M.corti lacked the ability for collagen deposition and 
encapsulation of the parasite, which led to in higher parasite burdens in the liver compared 
to normal mice (Pollacco, 1975). This capacity was restored when T-cells were injected into 
the host. Immunity to tetrathyridia is both cellular (Pollacco, 1975) and humoral (Kowalski 
and Thorson, 1972; Kazacos, 1976) and involves T-cell mediated antibody production, col­
lagen formation and encapsulationC Pciuxres e t «L,
2.1.7 Immunosuppression in mice infected with M.corti:
Mice infected with M.corti are immunosuppressed, which increases the longevity of the 
parasite and reduces host responsiveness to antigenic stimulation. Large amounts of non­
complement fixing, non-macrophage binding IgGl immunoglobulins are associated with 
larvae in high concentration in the serum of chronically infected intact mice. (Mitchell, 
Marchalonis, Smith, Nicholas and Warner, 1977). The presence of large amounts of
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IgGl suggests that this may be acting as a "blocking factor", preventing the access of more 
immunologically aggressive antibodies and cells late in the infection. The IgGl antibodies 
associated with parasites in chronically infected mice would therefore actually be host 
protective in preventing anaphylaxis and systemic decomplementation. Absorption of syn­
geneic cells and molecules is very low in infected mice compared to controls. (Mitchell £t 
a!., 1977). Confinement of antigen in the chronically inflamed peritoneal cavity and sub­
sequent local destruction may be responsible for immunosuppression in M.corti infected 
mice. Infected rats were also found to have a significantly increased concentration of 
serum corticosterone. The immunosuppression in M.corti infection may also be due to the 
continuous physiological stress (Chernin and Morinam, 1984). Sogandares Bernal and Voge 
(1978) demonstrated the presence of host IgG molecules on the tegument of M.corti. Cher­
nin and McLaren (1983) have also reported the presence of a layer of sulphated 
mucopolysacharides known to inhibit the binding of the C3 complement factor (Letanja
and Hammerberg, 1983) around tetrathyridia of M.corti. This may be symptomatic of the
tbe
ability of the parasite to evade^host’s immune response. Recent investigations by Chevis 
and Bryant (unpublished reports) suggest that the immunosuppression in mice infected with 
M.corti is due to the free radicals produced by macrophages.
2.2 Nematospiroides dubius 
2.2.1. General
There is a controversy regarding the names Nematospiroides dubius (Nematoda: 
Heligmosomidae) and Heligmosomoides polygyrus which are regarded as synonymous 
(Kerboenf, 1978). Both the names H.polygyrus and N.dubius (Cypess and Van Zandt, 1973; 
Behnke, 1982) have been used by investigators.
2.2.2 Life Cycle
The life cycle of N.dubius is direct, involving only one host with both free living and
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parasitic stages and takes approximately 14 days under optimal environmental conditions, 
for one generation interval. The first observations on N.dubius were made by Spurlock, 
(1943) followed by a brief description of the life cycle by Ehrenford (1954) and Fahmy 
(1956) outlined the pre-parasitic stages. A detailed description of the life cycle of N.dubius 
was reported by Bryant (1973a) followed by investigations into the growth and metabolism 
of the pre-parasitic (Bryant, 1973b) and the parasitic stages (Bryant, 1974).
N.dubius reproduces sexually in the intestinal lumen of the host, eggs accompanying 
voided faeces. The eggs contain fully developed larvae 28 h after being laid and hatch 
after 36-37 h, liberating the first larval stage (LI). Larvae feed on faecal microfauna, and 
28 and 29 h. after hatching moult to give rise to the second larval stage (L2) which, 17-20 h 
later undergoes a partial moult, to form the ensheathed infective non-feeding third stage 
larvae (L3) (Bryant, 1973b). Following ingestion by the host, the L3, under the influence of 
extrinsic and intrinsic stimuli, exsheath and penetrate into the intestinal mucosa after 24 h. 
At this stage N.dubius changes from a free living organism to a parasite. The parasitic 
larvae within the intestine develop, undergo two moults and emerge into the lumen of the 
intestine as young adults, approximately nine days post infection.
2.2.3 Host Range:
Natural infections of N.dubius are associated with members of the Cricetidae and 
Muridae. Under laboratory conditions the rat ( Cross, 1960; Liu and Ivey, 1961), guinea pig 
(Newton, Weinstein and Jones, 1959) and hamster (Cross and Duffy, 1963) have been used 
for N.dubius infections, though aided by immunosuppressants and or axenic technique. Sex, 
age and pregnancy significantly influence the establishment rates in the rat (Dobson, 1962). 
This abnormal host is able to encapsulate N.dubius larvae within connective tissue follow­
ing a strong inflammatory response and parasite longevity and fecundity are only one 
quarter of that observed in the laboratory mouse.
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Low cost, ease of maintenance and the availability of innumerable strains of mice 
favour the use of this parasite and the host as a laboratory model in which to investigate 
many aspects of nematodiasis. Primary infections are stable, persisting for 7-10 months 
(Spurlock, 1943; Williams, Pascoe and Behnke, 1982) and moderately pathogenic (Liu, 1965). 
Acquired immunity develops slowly (Behnke and Wakelin, 1977) and varies according to 
genotype (Husley, Day and Mitchell, 1980).
Many investigators have reported immunologically oriented investigations with 
N.dubius. These include studies associated with host specificity, innate immunity (Prowse, 
Mitchell, Ey and Jhenkin, 1979), the mechanism of immunity (Panter, 1969), including an­
tibody production, cross immunity and the transfer of immunity (Jones and Rubin, 1974, 
Dobson, 1982). Others have used this model for (a) investigating anthelmintic efficacy, 
(Hewitt and Gumble, 1957; Sheffield, Meisenhelder and Thompson, 1959; Sharpe, 1980; 
Jenkins and Ibarra, 1984), (b) immunosuppressant drugs, (c) making comparative studies 
with higher mammal/nematode systems, for example, endemic human hookworm (Necator 
americanus') infections (Bartlett and Ball, 1972), and metabolic effects associated with 
parasitism (Symons and Jones, 1970), and the development of anthelmintic resistance 
(Washington, unpublished thesis, 1981).
2.2.4 Pathological effects
Baker (1954) has described in detail, the pathology associated with N.dubius infection. 
Anaemia, enteritis, reduced peristalsis and splenomegaly were observed in inbred Webster 
mice infected with 400 L3 larvae. Larval penetration of the muscularis externa was as­
sociated with inflammation, necrosis and thrombi (Liu, 1965). The larvae are not encysted 
and movement in the muscularis mucosa, permits them to feed on surrounding tissue 
(Sukhdeo, O’Grady and Hsu, 1984). The emergence of young adult worms is accompanied 
by haemorrhage and the loss of mucosal and epithelial tissue (Liu, 1965), resulting in an
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anaemia characterized by reduction in erythrocyte count, haemoglobin level, packed cell 
volume and leucopenia (Baker, 1962). Multiple infections result in a more intense and rapid 
gastric eosinophilia, neutrophilia and leucocytosis (Liu, 1965; Panter, 1969a).
O'
Host resistance to N.dubius infection is influenced by age^sex (Dobson, 1961; Newton, 
Weinstein and Sawyer, 1962; Bawden, 1969; Dobson and Owen, 1978; Prowse, Mitchell, Ey 
& Jenkins, 1979 and Husley, Day et al.. 1980), genotype (Spurlock, 1943; Liu, 1966; Cypess 
and Zidian, 1975; Lueker and Hepler, 1975; Behnke and Wakelin, 1977; Prowse et al.. 1979); 
the method of sensitization, (Jones and Rubin, 1974; Behnke and Wakelin, 1977), the inter­
val between (Behnke and hannah, 1983) and number of N.dubius infections (Van Zandt, 
1961; Panter, 1969a).
2.2.5 Immunosuppression in mice infected with N.dubius
Mice with N.dubius infection have impaired immunological responses when challenged 
with a variety of viral, bacterial, metazoan, cellular and chemical antigens (Chowanie, 
Wescott and Congdon, 1972; Shimp, Crandell and Grandell, 1975; Behnke, 1982, Ali and Be­
hnke, 1984). Both adult and larval N.dubius appear to suppress homologous immunity 
(Hannah, Pritchard and Behnke, 1982). Serum from donor mice is more efficacious when 
taken four days after the infection was terminated rather than at the termination and sera 
from mice with a greater burden were more protective than sera from mice with lesser 
burdenS.These factors support the view that adult N.dubius is contributing to immunosup­
pression probably by interfering with immunological responses at the intestinal level 
(Behnke, Hannah and Pritchard, 1983). The immunosuppression of the host is a complex 
process and may be due to a combination of parasite induced factors such as intestinal 
damage or release of parasite excretory and secretory products (Ali and Behnke, 1983). 
Recent studies have also shown that immunosuppression was antigen specific (Pritchard, 
Ali and Behnke, 1984).
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2.3 Mebendazole
2.3.1 General
Mebendazole (methyl [5-(benzoyl)-lH-benzimidazol-2-yl] carbamate) is a broad spectrum 
anthelmintic effective against both nematodes and cestodes (Vanparijs and Thienpont, 
1973). Thienpont, Vanparijs and Hermans (1974) reported prophylactic and therapeutic ef­
fect of mebendazole against the larvae of Taenia taeniaeformis. Mebendazole at a dose rate 
of 250 ppm and over when administered orally inhibits cyst growth and after mebendazole 
treatment, all previously infected mice are resistant to a challenge dose of T,taeniaeformis
The effectiveness of mebendazole seemed to depend on the formulation of the drug and 
its route of administration (Heath, Christie and Chevis, (1975). Oral administration of 
mebendazole at a dose rate of lg/kg feed for 14 days killed mature and immature cys- 
ticerci of T .pisiformis in rabbits, and killed multiplying tetrathyridia of M.corti. A single 
subcutaneous injection of mebendazole in saline or in carrier results in the death of all 
M.corti larvae in four weeks, but the drug injected in saline or in carrier is ineffective 
against cysticerci of T.pisiformis in five weeks.
2.3.2 Mode of action of mebendazole
Mebendazole is relatively insoluble and hence poorly absorbed from the intestinal tract. 
It probably does not exert its effect through a single mode of action as a number of systems
eggs.
Structural formula
M
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in various species of parasites are affected. Mebendazole inhibits in vivo and in vitro 
glucose uptake by nematodes and cestodes (Van den Bossche, 1972, 1973, 1976). As a result 
of the inability to use exogenous glucose, the endogenous glycogen reserves in the muscle 
tissue are utilized, which leads to a decreased generation of energy rich phosphate bonds 
(Van den Bossche, 1972). Mebendazole induced glycogen depletion is secondary to the in­
hibitory effect of this drug on the glucose uptake (Van den Bossche, 1972).
Mebendazole also interferes with passive and enhanced glucose transport mechanisms 
such as the uptake of 3-0-methyl glucose and of the amino acids, proline, glycine and 
methionine in Ascaris suum (Van den Bossche and De Nollin, 1973). Mebendazole decreases 
the uptake of these compounds in the presence and absence of glucose.
In vitro uptake of fatty acids by Ascaris suum was not affected by mebendazole, when 
glucose was omitted from the medium, suggesting that mebendazole has no effect on 
transport mechanisms which depend on energy obtained from the catabolism of endogenous 
sources. (Van den Bossche and De Nollin, 1973).
In Fasciola heoatica. mebendazole does not affect glucose uptake, nor the mobilization 
of glycogen in vitro but adenine nucleotide levels are depressed. (Cornish and Bryant, 
1976). These investigators provide the alternative explanation for Van den Bossche’s results 
with Ascaris that mebendazole brings about depletion of ATP levels which, in turn 
diminishes the uptake of glucose. The difference between Ascaris and F.heoatica is ex­
plained by the difference in glucose uptake, which is an active process in Ascaris and pas­
sive in F.heoatica (Beames, 1971; Isseroff and Read, 1974). In vivo however, glycogen levels 
are depressed following mebendazole treatment (Cornish and Bryant, 1976; Rahman and 
Bryant, 1977), probably due to their detachment from the bile ducts and the utilisation of 
glycogen for maintainance.
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Moniezia expansa is also susceptible to mebendazole in vitro and in vivo. Uptake of
glucose from the medium by M.expansa is inhibited by mebendazole in vitro and in vivo
ft
(Rahman et at.. 1977). At the same time, glycogen content of the parasite is decreased. 
Treatment of M.expansa with mebendazole in vivo or in vitro causes decreased levels of 
ATP and ADP and total nucleotides (Rahman and Bryant, 1977; Rahman et al. 1977). The 
resulting reduced energy levels in the cestode may be responsible for decreased glucose up­
take. Mebendazole also reduced the production of succinate by inhibiting the phosphoenol- 
pyruvate carboxykinase (PEPK) reaction and the fumarate reductase system which results 
in the shift of flux from the succinate producing pathway to the lactate producing path­
way.
Mebendazole treatment of F.heoatica in vitro initially decreases ATP and increases 
AMP levels. Later, total nucleotides are depressed. The effect of mebendazole on end 
product formation was to increase initially the excretion of succinate which suggests that 
the conversion of succinate to propionate is inhibited. Later, excretion of lactate was also 
inhibited .
Mebendazole treatment induces the disappearance of the cytoplasmic microtubules of 
tegumental and intestinal cells of cestodes or nematodes, followed by a block in transport 
of secretory vesicles. The cellular injury caused by mebendazole treatment is irreversible 
and can ultimately lead to the death of the parasite (Borgers and De Nollin, 1975; Ver- 
heyen, Borgers, Vanparijs and Theinpont, 1976).
Mebendazole also has the capacity to bind to tubulin and inhibit the assembly of 
microtubules ( Friedman and Platzer, 1980). Mebendazole exerts its effects specifically on 
the parasite as the drug does not affect glucose uptake in rat intestine (Van den Bossche 
and De Nollin, 1973). No changes in the general and ultrastructure in jejunal absorptive 
cells of pigs were noticed (Borgers and De Nollin, 1975). Mebendazole could bind tw icer 
tightly to the parasite tubulin compared with the host which could be responsible for the
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apparently selective interaction of the drugs with the cytoplasmic microtubule of the 
parasite intestine (Kohler and Bachmann, 1980).
2.4 Levamisole
2.4.1 General
Levamisole hydrochloride, the L-isomer of the synthetic anthelmintic tetramisole was 
first described by Thienpont, Vanparijs, Raeymaekers, Vandenberk, Demoen, Allewijn, 
Marsboom, Niemegeers, Schellekens and Janssen in 1966. Since its discovery, this simple 
chemical has proved to be very effective against most gastrointestinal and pulmonary 
nematodes in man and animals. In vitro, levamisole paralyses the cestodes M.expansa and M. 
corti larvae and the trematode F. hepatica (Bennet, Behm & Bryant, 1978). Various factors 
prevent this effect being an anthelmintic in vivo.
2.4.2 Mode of action
Levamisole is a stable crystalline and water soluble hydrochloride of racemic 2,3,5,6- 
tetrahydro-6-phenyl-imidazo-(2,l -b)-thiazole. After oral or parenteral administration, it is 
rapidly absorbed from the gastro-intestinal tract and has a plasma half-life of several 
hours and reaches its highest blood level within 30 minutes in man and animals. It is exten­
sively metabolised in the liver and one of the metabolites 2-oxo-3-(2-mercaptoethyl)-5- 
phenyl-imidazoledine (OMPI) is known to be a very effective scavenger of free radicals.
Structural formula
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The earliest evidence that levamisole inhibits ^succinate dehydrogenase system of 
nematodes was presented by Van den Bossche and Janssen in 1967. Further investigations 
by Boczon in 1976 showed that levamisole inhibits succinate dehydrogenase and fumarate 
reductase activities in mitochondria prepared from the larvae of Trichinella spiralis. 
Levamisole inhibits fumarate reductase in a large number of parasitic nematodes and 
F.heoatica. but not in cestodes against which it is inactive (Van den Bossche, 1976). 
Levamisole also affects the nervous system of nematodes causing paralysis (Coles, 1977), 
which would account for its anthelmintic effect. At low concentrations levamisole stimu­
lates sympathetic and parasympathetic ganglia by lowering the membrane potential of 
muscle cells in both nematodes and man (Van Nueten, 1972; Coles and Jenkins, 1974 and 
Coles, East and Jenkins, 1975).
Sera from levamisole treated mice, rabbits and man were found to stimulate the 
biologic effects of levamisole itself (Symoens, Rosenthal, De Brabander and Goldstein, 
1979). This factor enhanced carbon clearance (Van Ginckel and Hoebeke, 1975), stimulated 
lymphocyte proliferation in vitro (Ivanyi and Lehner, 1977), restored immunological reac­
tivity of athymic mice (Renoux and Renoux, 1977), stabilized tumor remission and reduced 
tumour load in experimental systems (Symoens, Rosenthal, De Brabander and Goldstein, 
1977). The factor could not be detected in mice which failed to respond to treatment with 
levamisole; but non-responders reacted to serum factor in a similar way as responders 
treated with levamisole itself (Symoens, Rosenthal, De Brabander and Goldstein, 1979).
/
One of the major metabolites of levamisole in vivo. OMPI was reported to be more 
potent than the parent compound in enhancing carbon clearance in mice (Symoens, Rosen­
thal, De Brabander and Goldstein, 1979). In vivo studies have demonstrated that a thymic 
hormone isolated from mice has an identical effect to levamisole on the immune system 
(Galant, Lomdak and Eaten, 1976). Both levamisole and thymic factors have similar effects 
on cAMP and cGMP in lymphomyeloid target cells; increase of cAMP in precursor popula­
tions, increase of cGMP in mature effector cells. (Symoens, Rosenthal, De Brabander and
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Goldstein, 1979; Michalevicz, Many, Ramot and Trainin, 1978; Sunshine, Basch, Coffey, 
Cohen, Goldstein and Hadden, 1978). In view of the apparent similarities of the in vivo 
and some of the in vitro effects of levamisole and thymic hormones it was proposed that 
levamisole might (through the intermediate or a metabolite) activate a serum factor which 
would in turn combine with a cell membrane receptor for thymic hormones (Symoens, 
Rosenthal, de Brabander and Goldstein, 1979).
2.4.3 Immunostimulation
The immune stimulation effect of levamisole was first reported by Renoux and Renoux 
(1971), by demonstrating that tetramisole augmented the protective effect of a Brucella 
vaccine in mice. Since then, an intensive interdisciplinary research effort by both im­
munologists and clinicians has led to considerable progress in understanding the im- 
munopharmacological and clinical characterization of the immunoregulatory anthelmintic 
levamisole.
Levamisole has been shown to restore the compromised responses of polymorphonuclear 
leukocytes, monocytes, macrophages and T lymphocytes in a variety of systems both in vivo 
and in vitro (Symoens and Rosenthal, 1977). Thus, both monocyte and neutrophil motility 
and chemotoxis (Kelly, 1978;), phagocytosis (Symoens, Rosenthal, De Brabander and 
Goldstein, 1979; Molin and Stendahl, 1977; Van Ginckel and Hoebeke, 1975), lysosomal en­
zyme release intracellular killing and macrophage proliferation (Symoens, Rosenthal, De 
Brabander and Goldstein, 1979; Pelletier, Willoughby and Giroud, 1978) could be repaired, 
enhanced or modulated. T-lymphocyte proliferation, (Symoens, Rosenthal, De Brabander 
and Goldstein, 1979; Neubauer and Rabin, 1978), formation of E-rosettes (Michalevicz, 
Many, Ramot and Trainin, 1978; Lomnitzer and Rabson, 1978; Cock, De Cree and Ver- 
haegen, 1978), in vitro manifestation of cell mediated immunity (Windle, Wood and Bell, 
1978) and T-dependent antibody plaque formation (Renoux and Renoux, 1977), T-cell lym­
phocyte protein synthesis (Hadden, Coffey, Hadden, Lopez-Corrales and Sunshine, 1975; 
Symoens and Rosenthal, 1977) were also enhanced by levamisole. However, levamisole had
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little or no effect on existing serum immunoglobulin levels (De Diego, Garcia Carrillo and 
Trumper, 1974; Verhaegen, De Cree, Verbruggen, Hoebeke, De brabander and Brugmans, 
1973) or on specific antibody production to the particular bacterial, viral or cellular im­
munogen (De Diego, Garcia Carrillo, and Trumper, 1974; Fischer, Balk, Crumrine and Bass, 
1976; Flannery, Rolland and Nairn, 1975) In vivo, though not in vitro, levamisole was 
found to promote differentiation of pre-T cells to mature lymphocytes, thus mimicking the 
effect of thymic hormones (Symoens, Rosenthal, De Barbander and Goldstein, 1979). 
Levamisole treatment of congenitally athymic mice induced the expression of T-cell 
membrane markers on spleen cells (Renoux and Renoux, 1977). Restoration of genetically 
defective helper and suppressor cell function by levamisole administration in vivo was 
demonstrated by reappearance of responsiveness to sheep red blood cells in athymic 
animals (Renoux and Renoux, 1977). Clinically, cell-mediated immunity was reported to be 
reconstituted by levamisole therapy in children with primary immune defects.
Levamisole increases the binding capacity of E-rosette forming cells (Moncadla- 
Gonzales, rodrigues-Excobeso and Castanedo de Alba, 1976; Ramot, Biniaminue, Shadom 
and Rosenthal, 1976; Rosenthal, 1977; Verhaegenm De Cook and De Cree, 1977). Lomnitzer 
and Rabson (1978) have demonstrated an enhanced resynthesis of E-receptors which re­
stored E-rosette formation by trypsinized lymphocytes incubated in levamisole. Levamisole 
augments the T-cell mediated production of soluble mediators of delayed hypersensitivity 
(macrophage migration inhibitory factor and activating factor) by mitogen or antigen 
stimulated lymphocytes (Lieberman and Hsu, 1976).
Levamisole has little or no effect in healthy young people but restores to normal a 
variety of immunologic functions in elderly people. Thus, the main applications of 
levamisole are against infection due to immuno-deficiency, immunosuppression or auto­
immune diseases (Renoux, 1978). Improved immune responses have also been noted in im­
mune deficient diseases such as Wiskott-Aldrich Syndrome, Crohns disease, hypogam­
maglobulinemia and chronic mucocutaneous candidicases (Symoens et al.. 1979).
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2.5 Vitamin E
Vitamin E is the name applied to a group of fat soluble, unstable organic compounds 
known as the tocopherols. d-Alpha-tocopherol possesses the greatest degree of vitamin E ac­
tivity. The tocopherols are found in the germ oils of seeds such as wheat, corn and soybean 
and in alfalfa meal.
Vitamin E is known to have various biological activities such as fertility factor (Sure, 
1924), inhibition of human platelet aggregation (Steiner and Anastari, 1976) and stabi­
lization of biological membranes. Vitamin E deficiency causes encephalomalacia in chicks 
(Pappen Heimer and Goettsch, 1931 and Pappenheimer et al.. 1939; Scott, 1962), exudative 
diathesis in chicks, (Dam and Glavind, 1939) and muscular dystrophy in rabbit 
(Mackenzie, 1953).
Tocopherol deficiency in man causes steatorrhea due to persistant inability to absorb 
fats (Binder, Herting, Hurst, Finch and Spiro, 1965). The megaloblastic anemia of mal­
nourished Jordanian children has been attributed to vitamin E deficiency (Majaj, Dinning, 
Azzam and Darby, 1964). The brown bowel syndrome develops in adults with severe 
steatorrhea of long duration presumably as a result of excessive accumulation of oxidized 
lipids in the reticulo-endothelial cells of the intestinal tract (Toffer, Hukill and Spiro, 
1963). Vitamin E must be the major (and is quite probably the only) lipid-soluble, chain 
breaking (peroxyl radical-trapping) anti-oxidant in human blood plasma (Burton, Joyce 
and Ingold, 1982).
The functional defects associated with tocopherol depletion are probably related to the 
role of vitamin E as an anti-oxidant in preventing the peroxidation of highly unsaturated 
lipids. Gyorgy, Cogan and Rose (1952) have demonstrated that the evidence of vitamin E 
deficiency is a positive hydrogen peroxide erythrocyte hemolysis test. During incubation of 
red cells from tocopherol deficient animals (Tsen and Collier, I960;) or man (Century and
21
Hoewitt, 1960), abnormally high levels of lipid peroxide accumulate. Vitamin E is capable 
of preventing the oxidation of erythrocyte membrane lipids when the red cell is exposed to 
hydrogen peroxide. The absence of this vitamin leads to membrane-lipid destruction and 
subsequent haemolysis.
Vitamin E may be important in maintaining erythrocyte membrane integrity in the 
presence of increased oxidants. The anti-oxidant effect of tocopherol preserves reduced 
glutathione (GSH) stability through maintenance of sulfhydryl bonds (Lewis and Wills, 
1962). Tengerdy, Heinzerling, Brown and Mathias (1973), have also reported the enhancing 
effect of immune response by vitamin E. Vitamin E was reported to be a specific and ef­
fective stimulant of the humoral immune response, stimulating the primary development 
and/or proliferation of antibody producing cells, especially those producing IgG antibody. 
Vitamin E also stimulates co-operation between T and B cells in antibody production 
(Tanaka, Fujiwara and Torisu, 1979).
2.6 Butylated hydroxy Anisol (BHA)
BHA is normally a mixture of two isomers, 85% of 2-t-butyl-4-methoxyphenol and 15% 
of 3-t-butyl-4-methoxyphenol. BHT (2,6-Di-t-butyl-P-cresol), and BHA are now extensively 
used as anti-oxidants in fats for human consumption (Dugan, Marx, Weir and Kraybill, 
1954). The normal level of usage is 0.01-0.02 percent of the fat. These antioxidants do not 
have toxic effects when fed to several species of animals at a concentration, one hundred 
times their normal level of usage in human diets (Brown, Johnson, & O’halloman, 1959).
Structural formulae
Butylated Hydroxy Anisole
When given to rabbits, BHA as a single dose of lg., 60 percent was excreted in the urine as 
glucuronide, ethereal sulphate and free phenol in 24 hr. (Dacre, Denz and Kennedy (1956). 
Rats excreted 90 percent of a single dose (0.08 to O.lg) of BHA in urine. The urinary excre­
tion of BHT is less than that of BHA in rats (Ladomery, Ryan and Wright, 1963.) due to the 
lower polarity of BHT and the fact that the phenolic group is not available for conjugation 
with sulphate or glucuronic acid as it is in BHA (Dacre et al„ 1956). The slow excretion of 
BHT in urine has been reported by several investigators and is probably due to rapid en- 
tero hepatic circulation (Ladomery, et al.. 1963).
Autoxidation of unsaturated fatty acids involves the formation of free radicals during 
the induction period leading to the breakdown of carbon-carbon double bonds and con­
sequent rancidity. BHA and BHT act as antioxidants by accepting free radicals. Rats are 
the animals most frequently used for the in vivo studies of BHT, and the oral dose required 
to cause an increase in relative liver weight and in the concentrations of drug metabolizing
enzymes and urinary ascorbic^is about 500mg/kg body weight. So far as reproduction is 
concerned in the rat, BHA and BHT will not replace vitamin E, also an antioxidant, at a 
dietary level of 0.1 percent.
The effectiveness of BHA and BHT as antioxidants is probably to^certain extent due to
a/ci<i
their high solubility in fats and their extremely low solubility in aqu^us environments.
2.7 N,N’-Diphenyl-P-Phenylenediamine (DPPD)
Structural formulae
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The synthetic antioxidant DPPD is also used as a polymerization inhibitor and an­
tioxidant for rubber, petroleum oils and food. DPPD can replace vitamin E in some 
biological functions such as preventing muscular dystrophy and creatinuria in rabbits 
(Draper and Csallany, 1958), exudative diathesis in chicks (Mathias and Hogue, 1971), 
brown fat symptom in chicks (Dam, 1957), but is ineffective in preventing reproductive 
failure in rats. DPPD is also ineffective in restoring the IgG response to the vitamin E 
deficient mice, and is only partially effective in enhancing the immune response of mice 
fed normal, vitamin E containing diets (Tengerdy, Heinzerling, Brown and mathias, 1973).
2.8 AIM OF PROJECT
Synergy can be defined as the joint action of agents such that their combined effects 
are greater than the algebraic sum of their individual effects. Bennet et al..(1976) showed 
that if mebendazole was administered concurrently with levamisole, a synergistic effect 
was obtained against Mesocestoides corti larvae in mice, but this effect was destroyed by 
irradiation. These experiments suggested that a synergistic interaction between these drugs 
was mediated through a levamisole stimulated immune system.
Chevis and Bryant (unpublished observations) have also observed synergy between 
another benzimidazole derivative oxfendazole and vitamin E. The effect displayed by 
levamisole and vitamin E in synergising the anthelmintic activity of oxfendazole was at­
tributed to their ability to scavenge free radicals produced by macrophages in the 
peritoneal cavities of mice infected with Mesocestoides corti. These investigators suggested 
that immune suppression in Mesocestoides corti infection was mediated by macrophages 
and the removal of free radicals reverses this immune suppression to a certain extent, 
thereby restoring the ability of the host to attack the parasite.
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The present study was undertaken to determine whether this synergistic effect could be 
extended to mebendazole and synthetic antioxidants and whether the free radicals 
produced by activated macrophages are positive immunostimulants or immunosuppressents. 
To determine this, various antioxidants were used to remove the free radicals produced by 
the host immune system and to study the effect of this on the rate of multiplication of the 
larvae. An attempt was also made to study the differences in the susceptibility to Mesoces- 
toides corti infection according to the sex and strain of mice.
These experiments employed the Mesocestoides-mouse model and also the nematode 
parasite of mice, Nematosoiroides dubius.
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CHAPTER - 3
3.1 MATERIALS AND METHODS 
Parasites
3.1.1 Mesocestoides corti
A strain of Mesocestoides corti isolated by Specht and Voge (1965) and obtained by 
David Heath for a departmental stock was maintained by intraperitoneal serial passage in 
laboratory mice. Outbred Quackenbush mice were used for stock infections and experi­
ments.
3.1.2 Nematospiroides dubius
Quackenbush females were used as stock mice to maintain Nematospiroides dubius. The 
mice were infected with 1000 third stage larvae and 14 to 21 days later faeces were col­
lected on moist filter paper. The faeces were washed twice with distilled water, con­
centrated by centrifugation at 1200g for 10 minutes and then streaked on two layers of 
moist filter paper. The filter papers, placed in 8.5 cm petri dishes, were incubated at 20C in 
the dark at 95-100% relative humidity. The faecal cultures were aired each day and mois­
tened when necessary. Infective larvae (L3) were irrigated from the dish and lid 6 to 7 days 
later. The L3 were washed once with distilled water, centrifuged at l,000g for one minute 
and stored in culture flasks for 1 to 2 weeks prior to use.
The infective dose was calculated and prepared with the use of a 250 ul adjustable 
pipette (Pipetman 200 R.Gilsen, France) with a tip to which a 1.1 x 3.8 mm steel tube was 
fitted. Twelve to 15 aliquots of 200ul were counted and the pipette volume adjusted to al­
low the administration of a uniform infective dose. The same pipette and tip were used to
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infect mice with 100 L3 each.
Faecal Egg counts
One gram of faeces were collected from each group of mice and were placed in a 
measuring cylinder and the volume was made up to 25mls with saturated salt solution. The 
faeces were then mashed with a metal plunger until an even faecal suspension was ob­
tained. Harder pieces of faecal debris were separated from eggs by a wire mesh plunger. 
The suspension was agitated with the mesh plunger to ensure even egg distribution and 
then the suspension was sampled with a disposable pasteur pipette into a universal egg 
count slide (H.V.Whitlock). The eggs floated to the surface of the salt solution and were 
counted under the 40x objective of a light microscope.
Egg Hatch Assay
Faeces were collected from mice over a 15-20 minute interval, then cooled and softened 
for two to three hours in tap water at 4’c. A slurry was made using a glass stirring rod and 
transferred to a 9cm glass petridish. After filling the dish to the brim with saturated saline, 
a thin plastic disc (about 0.2mm thick) cut to the size of the dish, was placed on the surface 
for 15 minutes. Eggs which rose to the top were removed on the disc and washed from it 
with distilled water. The suspension was then diluted to a concentration of about 100 to 
200 eggs/ml. One ml of egg suspension was added to each of sealable plastic dishes to min­
imize concentration changes caused by evaporation. The depth of the liquid was about 3 
mm., sufficiently shallow to permit oxygenation. The incubations of 24 h to 48 h were used
cu
at 22 'C. Development was halted by adding„few drops of Lugol’s iodine. The number of 
larvae and unhatched eggs in each dish were counted under a dissecting microscope.
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Host
Two outbred strains, Quackenbush and Swiss White mice and three inbred strains, 
BalbC, CBA and C57 mice were used in the experiments. Ages ranged from 5 to 8 weeks.
3.2 Anthelmintics
Mebendazole was administered at a dose rate of 50 mg/kg feed in mice infected with 
Mesocestoides corti and 100 mg/kg feed in mice infected with Nematosoiroides dubius. The 
LD 50 values of mebendazole are greater than 1280 mg/kg of weight for mice, rats and 
guinea pigs (Marsboom, 1973). The amount of mebendazole consumed by the mice in the 
experiments was calculated daily from the amount of medicated feed the mice had eaten.
Levamisole is toxic to mice at concentrations of 40 mg/kg body weight/day or more [LD 
50 = 150 mg/kg body weight in mice (Bullock, Hand and Waletzky, 1968)]. Bennett et 
ai.,U976) demonstrated a cellular response in the mouse at a concentration of 10 mg/kg 
body weight/day. Levamisole at this concentration was also used by Cole (1980, un­
published Honours thesis ANU) in mice infected with Mesocestoides corti. He observed 
fewer capsules and significantly more parasites in the livers of levamisole treated mice 
compared to controls. Recent studies in mice indicated that 1.25 to 5 mg/kg doses of 
levamisole stimulate T-cell function, while higher doses have no effect, or suppress mouse 
T-cell populations (Van Wauwe and Van Nijen, 1977; Van Ginckel and Hoebke, 5 ; Renoux 
and Renoux, 1977). Morimoto, Abe, and Homma, (1979) also showed that a 5 month ad­
ministration of levamisole, at 2.5 mg/kg, 3 days/week, restored T-cell function in aged 
mice. Considering these observations, a dose rate of 5 mg/kg body weight of levamisole was 
used in the present study in mice infected with Mesocestoides corti. Since levamisole at this 
dose rate exhibits anthelmintic activity against Nematospiroides dubius. a dose rate of 2.5 
mg/kg body weight was administered to mice infected with N.dubius.
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3.3 Antioxidants
Vitamin E and synthetic antioxidants were used at a dose rate of lg/kg feed.
3.4 General Methods
3.4.1 Food
Mecon rat and mouse cubes were finely minced in a blender and mixed well with the 
appropriate amounts of mebendazole and antioxidants. Water was added and the resulting 
mixture divided into cubes on baking trays and left for about 6 hours in the oven at 75’c.
3.4.2 Infection and Recovery of parasites
Tetrathyridia were aseptically removed from the peritoneal cavities of stocks of in­
fected mice, killed by anaesthesia, and washed five times in sterile 0.85% NaCl with 500 
units penicillin and 500 mg streptomycin per ml.
Experimental mice were lightly anaesthetised with ether and 20 tetrathyridia suspended 
in sterile antibiotic 0.85 % NaCl were injected intraperitoneally using a 1 ml tuberculin 
syringe with a 21 gauge needle.
Experimental mice were heavily anaesthetised with diethyl ether and killed by cervical 
dislocation, the abdomens opened and intestines removed. The intestines and peritoneal 
cavities were washed in 0.85 % NaCl to remove adherent parasites and the fluid examined 
for organisms. The parasite burden in the livers was determined by mincing the livers into 
small pieces and digesting in 1% trypsin solution for 5 hours at 37’c. The number of larvae 
in the liver and peritoneal cavity was determined by direct count. Liver tissue from each 
treatment and control group was fixed, sectioned and stained using the procedure outlined 
below.
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Histology
Liver tissue was fixed overnight in Bouins fixative, placed in 70%, 90% and 100% al­
cohols for 11/2 hours each and given two, two and half hours change in iso-propanol. The 
iso-propanol was drained and the liver tissue given two 3 hour changes in hot wax (60’c). 
After embedding, sections were cut on the microtome. All sections were stained using 
Haematoxylin and Van Giesons stain. Haematoxylin is a general nuclear stain, which shows 
up the fine nuclear detail of leukocytes, while Van Giesons stains collagen a bright pink. 
Therefore both leukocyte response and collagen deposition can be demonstrated using this 
technique (Steven, 1977).
Measurement of food and water consumed by mice
The amount of mebendazole and/or antioxidants consumed by the mice in the experi­
ments was calculated daily from the amount of medicated feed the mice had eaten. Mice 
cubes mixed with anthelmintic and/or antioxidants were placed in the food compartment 
on the wire lid. A plastic lunch box without its top was covered with wire and wedged un­
der the food by means of a rubber cork. Thus, food dropped by mice feeding from the lid 
was collected in the tray. This amount was then added to the food left on the lid and sub- 
stracted from the original weight of food given to obtain the amount eaten. Strips of wood 
were also wired to the lid to prevent mice rolling food along the top of the cage and eating 
it elsewhere. The food droppings were sorted from the faeces by means of sieves.
To measure the water consumption, the following apparatus, adapted from that of Ben- 
net (personal communication) was designed and used. Three bars of wire were snipped 
from the wire lid of the mouse cage, so that a 50 ml syringe could be inserted. This sup­
ported a rubber corked water bottle with a metal nipple. Mice drank from the nipple 
through a hole cut in the syringe. Any spilt water was caught in a liquid paraffin layer at 
the base of the syringe. Sawdust was not used because mice managed to contaminate both 
the food trays and the syringe with it.
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3.5 Statistical methods
The parasite counts were analysed using the Wilcoxon two sample test for unpaired 
samples, and a p value of 0.05 or less was considered significant. To compare the results of 
two different experiments each individual count within one experiment was selected at 
random and expressed as a percentage of a randomly selected individual count of the con­
trol group. The set of percentages thus obtained for each experiment were analysed using 
the Wilcoxon two sample test.
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CHAPTER - 4
4.1 INTRODUCTION
Initial experiments were conducted to study the effect of each of the drugs and an­
tioxidants against Mesocestoides corti and Nematosoiroides dubius. Previous work on 
M.corti demonstrated that oral administration of mebendazole at a dose rate of lg/kg feed 
(approximately 50 mg/kg body weight) for 14 days removes M.corti infection in mice in­
fected with 0.1 ml of packed tetrathyridia (Heath, Christie and Chevis, 1975). The same 
dose rate was also used successfully against M.corti infection by Bennet et al.. (197S) in 
mice infected with 50 larvae each.
Bennet et al..(1979) have administered mebendazole as a constituent of peanut meal, the 
consumption of which was less compared to the Mecon rat and mouse cubes used in the 
present study. The number of larvae used for the initial inoculum is also less in the present 
study compared to the previous studies reported by Heath et al.. (1975) and Bennet et a\.. 
(1972). Considering these differences, a dose response experiment was conducted to deter­
mine the lowest effective dose of mebendazole per kg of feed.
Novak (1972) demonstrated that M.corti larvae multiply more rapidly in male rather 
than female mice and also indicated that strain differences between mice affected the rate 
of multiplication of the larvae. Susceptibility of inbred strains to infection with M.corti 
was also reported by White, Thompson and Penhale, (1981). In these experiments, inbred 
and outbred strains of mice were used to assess the susceptibility of these strains to infec­
tion with tetrathyridia of M.corti. The differences in the rate of multiplication of larvae in 
male and female mice of an outbred strain (Quackenbush) and an inbred strain (CBA) was 
also studied.
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4.2 Methods
Experiment 4.2.1, 4.2.2 and 4.2.3.
Effect of Mebendazole on Nematospiroides dubius.
Thirty five female Quackenbush mice were infected orally with 100 third stage larvae 
of N.dubius and divided into 5 groups. Group 1 was treated as a control and 4 groups were 
treated with 2mg, 4mg, 6mg and 8 mg. of mebendazole respectively. Mebendazole ad­
ministration in the diet was started from day 14 post infection and continued for seven 
days. During the period of anthelmintic treatment, the faeces from each group were col­
lected every day and examined for egg production. The eggs were cultured and the per­
centage of eggs hatched were determined from each treatment group. Since mebendazole at 
S
these dose rate^ had no effect on the egg production and survival of adult worms, Experi­
ment 4.2.1 was repeated with increased dose rates of mebendazole at 10mg, 15mg, 20mg and 
25mg (Experiment 4.2.2) and 50mg, 100mg, 150mg and 200mg (Experiment 4.2.3).
Experiment 4.2.4.
Three groups of five Quackenbush female mice were infected with 100 third stage 
larvae of N.dubius each and the first group was treated as control and two groups were 
treated with 5 mg and 2.5 mg/kg body weight of levamisole respectively in drinking water 
for eight days. During the experimental period faeces were examined for egg production 
and the percentage of eggs hatched was determined. At the end of treatment, the mice were 
killed and the surviving worms were recovered and counted.
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Experiment 4.2.5.
Effect of mebendazole and antioxidants on tetrathyridia of M. corti.
Forty male Quackenbush mice were infected with 20 M.corti larvae each and divided 
into eight groups. Group 1 was treated as control and the rest of the groups were given dif­
ferent dose rates of mebendazole in the diet for five days from day one post-infection. All 
groups were killed on day 15 post infection and the number of larvae in the peritoneal 
cavities and livers were counted. £ ßs^er fo 7ib^U- 4-*1 -bv u^crma+vc 0
Experiment 4.2.6.
Male Quackenbush mice infected with M.corti larvae were treated with different dose 
rates of vitamin E, incorporated in diet. Treatment started from the day of infection and 
continued for twenty days. Mice were killed on day twenty one and the parasites were
recovered. The liver and spleen from each infected animal were isolated and weighed,
-4o 'ieviAn - <3r’ b  Oo dcßß- VcJib)’
Experiment 4.2.7.
Experim ent 4.2.6 was repeated with d iffreren t dose rates of N ,N -D iphenyl-P- 
Phenylenediamine (DPPD) instead of vitamin E.
Experiment 4.2.8.
Groups of 5 mice from each strain (Quackenbush male and female, CBA male and 
female, Swiss white male, BalbC male and C57 male mice) were infected intraperitoneally 
with 20 tetrathyridia of Mesocestoides corti each and were fed on Mecon rat and mice 
cubes and tapwater. Twenty days post-infection, all mice were killed and the number of
34
larvae in the peritoneal cavity and liver were counted.
4.3 Results
Results are presented in the figures and also in the numerical form in tables in the ap­
pendix. This convention is followed for all the figures.
Experiment-4.2.1.
Effect of Mebendazole on Nematospiroides dubius.
Figure 4.b (Table 4.2) represents the number of eggs/gram of faeces in the control and 
treatment groups. It is evident from these observations that a dose rate of 8 mg/kg feed had 
no significant effect on the egg production of adult worms. Mebendazole at this dose rate 
had no ovicidal effect, (fig 4.C)
Experiment 4.2.2.
The results are presented in fig. 4.d, and table 4.3. Mebendazole at a dose rate up to 25 
mg/kg feed had no significant effect on the survival or egg production by the adult worms. 
The embryotoxic effect of mebendazole was observed at a dose rate of 15 mg/kg feed and 
above, after three days of administration. (Fig-4e)
Experiment 4.2.3.
Figure 4 .fan d  Table-4.4 represent the no. of eggs produced/gram of faeces. 50 mg of 
mebendazole/kg of feed has significantly reduced the egg production from the controls and 
also exhibited ovicidal effect but was ineffective against adult worms. At a dose rate of
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100 mg/kg feed and above, mebendazole was ovicidal and also eliminated significant num­
ber of adult worms (Fig 4.g). Mebendazole administration at a dose rate of 200 mg/kg feed 
eliminated all the worms after one day’s treatment and none were recovered at the end of 
experimental period.
Figure 4.h represents the number of surviving worms recovered and the amount of 
mebendazole consumed by each mouse as determined by the amount of medicated food 
eaten. No significant difference was observed in the amount of food consumed/mouse/day 
between control group and treated groups which shows that incorporation of mebendazole 
has not reduced the palatability of the food.
Experiment 4.2.4.
Effect of Levamisole on Nematospiroides dubius.
The results are presented in Table - 4.5. Levamisole at a dose rate of 5 mg/kg body 
weight had anthelmintic effect on Nematospiroides dubius and eliminated more than 50% 
of the worms from control group. Levamisole at a dose rate of 2.5 mg/kg body weight had 
no anthelmintic effect on the worms. Hence this dose rate was used in subsequent experi­
ments in combination with mebendazole. Levamisole even at a dose rate of 5 mg/kg body 
weight does not exhibit ovicidal effect.
Experiment 4.2.5.
The results are presented in Fig.4.a and the~Table 4.1.The average number of parasites 
recovered is plotted against the amount of mebendazole consumed. In the controls, there 
was a four fold increase in the number of parasites in fifteen days. The administration of 
mebendazole at a dose rate of 25mg per kg feed had no effect on the parasites and the 
parasite numbers recovered were not significantly different from the controls. Fifty mg of 
mebendazole per kg feed was effective in reducing the parasite numbers to half the num-
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Figure 4.a
The effect of oral administration of different 
dose rates of mebendazole to mice infected with 
tetrathyridia of Mesocestoides corti.
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Fig. - 4.b
QB Female mice infected with Nematospiroides dubius 
and treated with different dose rates of Mebendazole 
Average Number of eggs produced per gram of faeces
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Fig. - 4.c
QB Female mice infected with Nematospiroides dubius 
and treated with different dose rates of Mebendazole 
Percentage of eggs hatched
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Fig. - 4.d
QB female mice infected with Nematospiroides dubius 
and treated with different dose rates of Mebendazole 
Average number of eggs produced per gram of faeces
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Fig. -  4.e
QB Female mice infected with Nematospiroides dubius 
and treated with different dose rates of Mebendazole 
percentage of eggs hatched
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Fig. - 4.f
QB Female mice infected with Nematospiroides dubius 
and treated with different dose rates of Mebendazole 
Average number of eggs produced per gram of faeces
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Fig. -  4.g
QB Female mice infected with Nematospiroides dubius 
and treated with different dose rates of mebendazole 
Percentage of eggs hatched
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Figure 4.h
Mebendazole dose response in mice infected 
with Nematospiroides dubius.
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ber of larvae intially inoculated. A dose rate of 100 mg of mebendazole per kg feed was 
much more effective in reducing the parasite numbers to 1 / 6th of the larvae initially in­
oculated. A dose rate of 150 mg/kg feed and above killed all the larvae and none were 
recovered after five days of administration.
Experiment: 4.2.6.
Vitamin E dose response in mice infected with Mesocestoides corti.
Results are presented in fig. 4.i and Table-4.6. Continued multiplication of larvae in 
mice was observed in both control and vitamin E treated groups. Significantly increased
fbe. r^Cxjon 1^
numbers of parasites were observed in^vitamin E treated groups compared to controls. 
Vitamin E treatment at a dose rate of 12,800 mg/kg feed had no significant effect on the 
parasite numbers both in peritoneal cavities and livers compared to controls. No trace of 
dead or disintegrating parasites were found in either control or treated groups. Regardless 
of the differences in the rate of multiplication, the relative distribution of tetraythyridia 
between peritoneal cavities and livers appeared similar in control and treated groups, ex­
cept in mice treated with 200mg of vitamin E, where the number of liver parasites was sig­
nificantly higher compared to peritoneal cavities. Vitamin E treatment also increased the 
weight of liver and spleen significantly from the controls (Table - 4.7) (Fig-4.j). Vitamin E 
at a dose rate of 12,800 mg/kg feed had no significant effect on the liver and spleen 
weight.
Experiment 4.2.7.
DPPD dose response in Mesocestoides corti infections.
Fig. 4.k and Table-4.8 represent the number of parasites recovered from peritoneal 
cavities and livers of mice treated with different dose rates of DPPD. DPPD treatment has 
also increased the number of parasites from the peritoneal cavities and livers significantly 
from the controls.
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Figure 4.i
Effect of Vitamin E on tetrathyridia of 
Mesocestoides corti. Number of parasites 
recovered from peritoneal cavities and livers.
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Figure 4.j
Liver and spleen weights of mice infected with 
tetrathyridia of Mesocestoides corti and treated 
with Vitamin E.
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Figure 4.k
Effect of various dose rates of DPPD on 
tetrathyridia of Mesocestoides corti. Number of 
parasites recovered from paritoneal cavities 
and livers.
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The differences in the parasite numbers between peritoneal cavities and livers are more 
significant in DPPD treatment groups compared to controls. DPPD Treatment has also in­
creased the liver weights of the infected mice but had no effect on the weights of spleen 
(Fig.4.1, Table 4.9).
Experiment 4.2.8.
The results are given in the figure 4.m. and also presented in numerical form in Table 
-4.10. Rapid multiplication of the larvae was observed in both inbred and outbred strains 
of mice. The relative distribution of tetrathyridia between the peritoneal cavities and 
livers of untreated control group was similar in the present study. After 20 days of infec­
tion, there was a significantly greater number of parasites recovered from the livers of 
Swiss white and BalbC male mice compared to the peritoneal cavities, whereas in CBA and 
C57 male mice, a slightly increased number of parasites were recovered from peritoneal 
cavities, compared to liver parasites. In female QB and CBA mice, a significantly reduced 
number of parasites were recovered from livers compared to peritoneal cavities.
There was a large intrastrain variation in the recovery of parasites except in QB and 
C57 male mice, as expressed by the standard error of mean. Among the five strains of mice 
used in the present study, CBA male mice were found to be highly susceptible to M.corti 
infection, followed by Swiss white mice. A lower rate of proliferation of tetrathyridia in 
the peritoneal cavities and livers was observed in QB and C57 males. Significant difference 
in the rate of multiplication of the larvae was observed between male and female mice of 
QB and CBA mice, but the differences were not significant in the peritoneal parasites.
4.4 Discussion
The efficacy of an anti-parasitic drug will depend on the toxic concentration being 
presented to the parasite for sufficient time to lead to irreversible damage.
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Figure 4.1
Liver and spleen weights of mice infected with 
terathyridia of Mesocestoides corti and treated 
with DPPD.
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Figure 4.m
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of different 
strains of mice.
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The minimum amount of mebendazole that is required to achieve antiparasite activity 
when presented constantly for one week is 50 mg/kg feed in mice infected with Mesoces- 
toides corti. Continuous oral administration of mebendazole maintains a low but long last­
ing serum level of the drug which is effective in killing the parasites.
Compared to M.corti. Nematospiroides dubius is more resistant to mebendazole treat­
ment, even though it is situated in the small intestine of mice. M.corti are bathed in the 
plasma of peritoneal cavity and are exposed directly to the drug in the liver. For this 
reason it may be more susceptible than N.dubius that feeds on intestinal mucosa of infected 
mice. Levamisole at a dose rate of 5 mg/kg body weight on the other hand was effective in 
removing more than 50% of the adult N.dubius from controls,. N.dubius has been shown to 
be reversibly paralysed by levamisole in vitro (Coles. 1977).
Administration of antioxidants increases the rate of multiplication of M.corti larvae 
both in peritoneal cavities and livers but the increase is not dose dependant. Vitamin E at a 
dose rate of 200mg/kg feed and DPPD at a dose rate of 400mg/kg feed has increased the 
number of liver parasites significantly from the other treatment groups. The treatment of 
infected mice with vitamin E and DPPD has increased liver weight significantly from the 
controls. Reversible hepatomegaly is one of the early and striking abnormalities observed 
in rodents treated with moderately high doses of BHA and BHT (Brown et al.. 1967). The 
reason for the liver enlargement could be due to increased activity of liver processing en­
zymes or altered activity of liver processing enzymes or due to histopathological changes. 
No abnormal histopathological changes associated with the increase in relative weight of 
the liver compared to controls was observed in the present study. Liver enlargement in 
these treatments could, perhaps be due to hyperfunctional response associated with induc­
tion of microsomal processing enzymes.
A significant increase in the weight of spleen was also observed in vitamin E treated
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groups compared to controls, indicating perhaps a general proliferation stimulus in this 
lymphopoietic organ. Many investigators have reported the accumulation of vitamin E in 
lymphopoietic tissues. Tengerdy, Heinzerling, Brown and Mathias (1973) have also reported 
that vitamin E supplement in mice increases the IgG production. These two factors indicate 
that vitamin E probably increases the number of antibody producing cells, rather than in­
creasing antibody production by single antibody producing cells.
Novak (1972) demonstrated that tetrathyridia multiply more rapidly in male rather 
than female mice. An extremely low parasite burden was found in female Quackenbush 
mice by Cole (1980, unpublished Honours thesis). The decrease in the resistance of female 
QB mice, since reported by Cole et al. (1980), could be due to changes in the environmental 
factors or genetic changes in the mouse strain or the parasite. Novak (1974) reported that 
gonadectomy depresses the liver infection in males but enhances it in females. Removal of 
ovaries, the main source of oestrogen, intensifies the invasion of tetrathyridia into livers. 
The decreased rate of multiplication of tetrathyridia in the livers of QB and CBA females 
observed in the present study is probably due to the influence of sex hormones. Reduced 
rate of multiplication of larvae in C57BL/6 mice and an increased susceptibility of CBA/H 
mice was also reported by White et al.. (1982).
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CHAPTER - 5 Combined treatment of antioxidants and Levamisole.
5.1 General
fl-corW
In these experiments^ infected mice were treated with levamisole, vitamin E and other 
synthetic antioxidants to study the possible existence of synergy or additive effect among 
the antioxidants and levamisole. Healthy adult male and female Quackenbush and CBA 
mice were used to examine whether there is any variation in the response to the above 
treatment according to the strain and sex of mice. Similar treatments were also studied in 
the nematode parasite, Nematospiroides dubius.
5.2 Methods 
Experiment.5.1.1.
Eight groups of five Quackenbush male mice each were infected with Mesocestoides 
corti and treated with levamisole, vitamin E and BHA on their own or in combination. The 
antioxidants were given in the diet and the levamisole was administered through the drink­
ing water. Treatment started from the day of infection and continued for twenty days. 
Mice were killed on day 21 post infection and the number of larvae recovered were 
counted.
Experiments 5.1.2, 5.1.3 & 5.1.4.
Eexperiment 5.1.1 was repeated in Quackenbush female, CBA male and female mice in 
experiments 5.1.2, 5.1.3 & 5.1.4 respectively.
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Experiments 5.1.5 & 5.1.6.
Experiment 5.1.1. was repeated in Quackenbush & CB A male mice, replacing BHA with 
the other synthetic anti-oxidant DPPD.
Two x 0.5 cm cubes of infected liver from Quackenbush male mice from each treatment 
group were fixed and sectioned for histology studies.
To evaluate drug action in the liver against Mesocestoides corti. the leukocyte and col­
lagen area around ten parasites from each treatment group was magnified using the Nikon 
Microprojector and drawn on A4 paper. This area was then estimated using the "shape" 
programme on the Intercolour and adjusted back to original size. Results were analysed 
statistically for differences among different treatment groups.
Nematospiroides dubius:
Experiment 5.2.1.
Groups of five Quackenbush female mice were infected with 100 third stage larvae 
each and were given antioxidants and/or levamisole, from day 14 post infection for eight 
days. During the experimental period, faeces were collected from each treatment group and 
examined for egg production. The eggs were also incubated and the percentage of eggs 
hatched from each group was determined. On day 9 post treatment, mice were killed and 
the worms were recovered from the intestine and counted.
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Experiment 5.2.2.
The above experiment was repeated with DPPD, replacing BHA.
5.3 Results 
Experiment 5.1.1.
The results are presented in fig. 5.a (Table 5.1). The average number of parasites 
recovered was plotted against the treatment group from peritoneal cavities and livers. In 
the control group, there was a ten fold increase in the larvae in 20 days in QB male mice. 
Treatment with levamisole and/or antioxidants increased the number of parasites in both 
peritoneal cavities and livers, which is significantly different from the controls. Combined 
treatments of antioxidants and levamisole were more effective in increasing the parasite 
numbers both in peritoneal cavities and livers compared to their single treatments. The 
highest number of larvae was recovered when two antioxidants were used in combination. 
The relative distribution of parasites was nearly equal between peritoneal cavities and 
livers of control group, where as a significantly increased number of parasites were 
recovered from the livers of single and combined treatment groups, except in the an­
tioxidants and antioxicants and levamisole treatment group.
Experiment 5.1.2.
The results are presented in fig: 5.b (Table-5.2). Treatment with antioxidants and 
levamisole significantly increased the parasite numbers both in Peritoneal cavities and 
livers as compared to controls except in the single treatment group of BHA, in the 
peritoneal cavities. The highest number of parasites were recovered when both the an­
tioxidants were used together but the combination treatment of levamisole and an-
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Figure 5.a
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of QB male 
mice following treatment with Vitamin Ef BHA 
and levamisole on its own or in combination.
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Figure 5.b
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of QB female 
mice following treatment with Vitamin E, BHA 
and levamisole on its own or in combination.
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Figure 5.d
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of CBA female 
mice following treatment with vitamin E, BHA 
and Levamisole.
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peritoneal cavities and livers where as their single treatments had significant effect only 
on the liver parasites. Unlike the male mice, the number of parasites from the livers is sig­
nificantly less than the larvae from peritoneal cavities. Parasite numbers in the groups 
treated with antioxidants and levamisole are not significantly different from their single 
treatments, whereas both the antioxidants together have increased the parasite numbers 
significantly over their single treatment groups.
Experiment 5.1.5 & 5.1.6.
The results are presented in fig. 5.e (Table-5.5) and 5.f (Table-5.6) for QB and CBA 
males respectively. DPPD had an effect similar to BHA in increasing the number of 
parasites in peritoneal cavities and livers of both QB and CBA male mice. DPPD, when 
used together with vitamin E, does not exhibit additive effect except in the liver parasites 
of Quackenbush males and the parasite numbers are not significantly different from their 
single treatment groups. No uniform pattern was observed in the relative distribution of 
parasites between peritoneal cavities and livers.
No dead or degenerated parasites were recovered either from peritoneal cavities or 
livers of QB and CBA mice. No synergistic or additive effect was observed between an­
tioxidants and levamisole. Single treatments with antioxidants and levamisole were equally 
effective as combined treatments. Two antioxidants, vitamin E and BHA together are more 
effective, compared to their single treatments. No such additive effect was observed when 
BHA was replaced by DPPD.
Liver Histology
Liver histology was studied only in Quackenbush male mice. The area infiltrated by 
leukocytes around the parasites from different treatment groups is shown in Table - 5.7. 
Considerable amount of cellular response around the parasite was observed from the con-
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Figure 5.e
Tetrathyridia of Mesocestoides corti recovered 
from QB male mice following treatment with vitamin 
E, DPPD and levamisole on its own or in 
combination.
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Figure 5.f
Tetrathyridia of Mesocestoides corti recovered 
from CBA male mice following treatment with vitamin 
E, DPPD and levamisole on its own or in 
combination.
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trol group but there was no encapsulation. The cellular response around BHA treated 
parasites was not significantly different from the control group. More cellular response was 
observed around the larvae treated with vitamin E, but the difference proved not to be 
statistically significant. Levamisole treatment significantly increased the cellular response 
around the parasite with the formation of collagen capsules. The combined treatment of 
antioxidants with levamisole was not different from the levamisole treatment alone. The 
cellular response around the parasites treated with vitamin E and BHA was also not sig­
nificantly different from controls.
Food and water intake were measured in Quackenbush male mice during the first ten 
days of the experimental period using the experimental design described in chapter-2. 
Results are presented in Table-5.8 and 5.9 for food and water respectively. Note that the 
food consumption of treatment groups was not significantly different from the control 
group. There was no significant difference in the liquid intake in the mice given 
levamisole and water compared to the control group.
Larvae recovered from the peritoneal cavities and livers of antioxidant and levamisole 
treatment groups appeared large compared to those from the control group. No difference 
in the proportion of cephalic and acephalic larvae was observed between control and 
treatment groups.
Experiment 5.2.1.
The average number of eggs produced by each treatment and control group per gram of 
faeces is represented in fig-5.g and Table-5.10 and the percentage of eggs hatched in fig- 
5.h. Antioxidant and levamisole treatments had no significant effect on the egg production 
by the adult worms and did not exhibit ovicidal effect compared to control group in eight 
days of treatment. The number of surviving worms recovered from the treatment groups is
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Fig. -  5.g
QB Female mice infected with Nematospiroides dubius 
and treated with Vitamin Ef Levamisole and BHA 
on its own or in combination.
Average Number of Eggs produced per gram of faeces.
Treatment Groups:
A Control
B : BHA 
C Vitamin E
D Levamisole
E Vitamin E + Levamisole 
F BHA + Levamisole
G BHA 4-  Vitamin E
H BHA + Vitamin E + Levamisole.
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Fig. -  5.h
QB female mice infected with Nematospiroides dubius 
and treated with Vitamin E, BHA and Levamisole 
on its own or in combination.
Percentage of eggs hatched
Treatment Groups:
A : Control 
B : BHA 
C Vitamin E 
D : Levamisole 
E Vitamin E + Levamisole 
F BHA + Levamisole
G BHA + Vitamin E
H : BHA + Vitamin E + Levamisole
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also not significantly different from controls.
Experiment 5.2.2.
Similar results were observed when BHA was replaced by DPPD and the data is 
presented in Fig-5.i and Fig-5.j ( Table-5.11) for egg production by the adult worms, and 
percentage of eggs hatched respectively.
5.4 Discussion
Differences observed in response to antioxidant and levamisole treatment in QB and 
CBA male and female mice may be due to factors such as age, sex, genetic make up, health 
condition, body weight, differences in absorption, distribution, metabolism and excretion 
of the compound and the influence of hormones.
Levamisole and antioxidant treatment had no significant effect on the nematode 
N.dubius. whereas a significant increase in the rate of multiplication of M.corti larvae was
cun
observed in infected mice. BHA in combination with vitamin E exhibited, additive effect, 
but this combined effect was not seen when both the antioxidants were used with 
levamisole. DPPD had no such additive effect when combined with vitamin E.
Among various biological effects, the best documented property of vitamin E is its
(S/YnoCW, gjfc.al v
powerful antioxidant effect^ One of the metabolites of levamisole, OMPI. was reported to 
be an effective free radical scavenger, 100 times more potent than the parent compoundjC^"^1^4 
The only known common characteristic of levamisole, vitamin E and synthetic antioxidants 
is their ability to interfere with free radicals. So, the circumstantial evidence presented in 
these experiments suggests that the increase in the rate of multiplication of Mesocestoides
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Fig. 5.i
QB Female mice infected with Nematospiroides dubius 
and treated with DPPD, Vitamin E, and Levamisole 
on its own or in combination 
Number of eggs produced per gram of faeces
Treatment Groups:
A Control 
B : Vitamin E 
C Levamisole 
D : DPPD
E : Vitamin E + DPPD 
F Levamisole + DPPD 
G : Vitamin E + Levamisole 
H Vitamin E + Levamisole + DPPD
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Fig. - 5.j
QB Female mice infected with Nematospiroides dubius 
and treated with Vitamin E., DPPD and Levamisole 
on its own or in combination 
Percentage of eggs hatched
Treatment Groups:
A Control 
B : Vitamin E
C : Levamisole
D : DPPD
E Vitamin E + DPPD
F Levamisole + DPPD
G : Vitamin E + Levamisole
H : Vitamin E + Levamisole + DPPD
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corti larvae in the treatment groups is probably due to the removal of oxidative metabolites 
released by the host immune system. Pollaco et al.. (1978) have demonstrated that an active 
cellular infiltration of the mouse peritoneal cavity occurs in response to M.corti challenge. 
This cellular infiltration is a 20 fold increase of eosinophils and macrophages which are 
enlarged and morphologically active. Further work by Johnson, Metcalf, Nicholas, Mckenie 
and Mitchell (1980) has shown that activation of eosinophils in the peritoneal cavity in 
response to M.corti challenge is T-cell dependant. Alveolar and peritoneal macrophages can 
generate hydrogen peroxide and superoxide anion, which is believed to be responsible for 
their cytotoxic activity. (Nathan, Brukner & Silverstein, 1979). Macrophages are known to 
release superoxide in amounts similar to those released by granulocytes. (Babior, Curnutte 
and Kipnes, 1975). Macrophages, induced in a manner that makes them capable of produc­
ing hydrogen peroxide are not only cytotoxic, but also have a cytostatic effect on normal 
syngeneic cells (Meitzer, Tucker and Breur, 1975). Thus, the greater oxidative metabolic 
response of the activated macrophages could play a significant role in accelerated capacity 
to effect cell mediated immunity.
In vivo studies have demonstrated the ability of superoxide dismutase to suppress car­
rageenan induced inflammation (Huber, & Saifer, 1977). Rats with experim ental 
rheumatoid arthritis, treated with superoxidedismutase show 30% decrease in inflammatory 
changes of joints after daily injections of superoxide dismutase, while mice with glomerulo 
nephritis, treated with superoxide dismutase on alternative days demonstrate decreased 
mortality, decreased antibody titer and decreased immunoglobulin deposition in glomeruli 
(Huber & Saifer, 1977). Recent investigations by Choudhri and Clark (1986) have also 
shown that free radicals are involved in the activation of T-lymphocytes as positive 
mediators, so that their removal by the free radical scavengers suppresses T-cell activation 
at some stage prior to the expression of interleukin-2 receptors. It is possible that this 
mechanism may be related to the complex series of metabolic events that generate intracel­
lular signals such as the metabolism of arachidonic acid. This compound is an intermediate
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on the pathway that leads to the production of prostaglandins and leukotrienes, substances 
known to regulate T-cell responses. The inhibition of one or more of these co-ordinate sys­
tems may result in a diminution of the physiological response stimulated by the antigen.
The circumstantial evidence presented in the present study suggests that the removal of 
free radicals by the scavengers might have interfered with the cell-mediated immunity at 
some stage, as described above, increasing the rate of multiplication of the larvae. More in­
vestigations with pharmacological inhibitors are essential to explain the role of free radi­
cals in mice infected with M.corti.
Liver histology studies show a significant increase in cellular infiltration and also the 
collagenous deposition around the parasite in the levamisole treatment group. However, this 
is not a comprehensive assessment of the total cellular and collagen response in the liver, 
but only a measure of this response in relation to each parasite. Evidence from the histol­
ogy studies has also shown that a number of parasites in the liver matrix of all treatments 
were completely free from leukocyte or collagen response, despite high immune responses 
to other parasites. This suggests that these parasites may have only recently migrated into 
liver from the peritoneal cavity. Specht and Widmer (1972) after extensive studies on 
M.corti larvae, suggest that the liver provides the proximity to the blood flow vital for the 
growth and multiplication of larva. Pollaco et al..(1978) have reported that collagen forma­
tion mediated by T-cells in response to M.corti acts to limit severely the proliferation of 
parasites in the liver. Various studies reported on the effect of levamisole on the mouse 
immune system have suggested that levamisole stimulates granulocyte and macrophage 
function rather than proliferation (Van Ginckel et al.. 1975; Cruchaud, Berney, & Welsher, 
1979; Gozzo, and Hanson, 1979). A massive granulocyte response to M.corti infection in 
mice was also demonstrated by Specht and Widmer, (1972). Levamisole is also capable of 
stimulating chemotaxis and random movement of granulocytes in mice. (Cruchaud et al.. 
1979).
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Therefore, increased proliferation of granulocytes in response to M.corti. coupled with an 
enhanced ability of these cells to penetrate to the site of damage may have resulted in 
higher concentration of these cells around each parasite.
Pollacco et al.. (1978) reported that collagen deposition in the mouse in response to 
M.corti larvae was mediated by T-cells. Since levamisole stimulates T-cell function, the in­
creased collagen deposition suggests that levamisole enhances T-cell collagen formation 
(Svmoens et al.. 1977). Thus, both leukocyte and collagen response to M.corti larvae appear 
to be stimulated by levamisole.
The larvae are capable of migrating at a sufficient rate to avoid most of the immune 
responses in the liver (Specht et al.. 1972). Leukocyte response and collagen formation is in 
response to hepatic damage rather than the migrating larvae. However, levamisole en­
hanced collagen formation is not effective in restricting the movement of the parasite in 
the liver matrix at this stage of infection. Immobilised parasites trapped in the liver matrix 
should elicit an increased antigenic response as neutrophils and eosinophils can surround 
the parasites and destroy them. This in turn should cause a stimulation and proliferation of 
leukocytes in response to other parasites. After a few larvae have penetrated the liver, fur­
ther penetration of larvae from the peritoneal cavity would be into an immunologically 
enhanced environment and the parasite numbers should significantly decrease. On the 
other hand, significantly increased numbers of liver parasites have been observed in the 
levamisole treated groups.
The bulk of the literature also demonstrates that levamisole does not enhance immunity
in healthy animals (Symoens and Rosenthal, 1977). The major effect of levamisole is in
immune deficient animals or in enhancing the immune response to an antigenic challenge
(Renoux and Renoux, 1974). Though levamisole stimulates an enhanced concentration of
granulocytes around the parasite, their effect on the larvae may be considerably reduced
by scavenging of free radicals produced by these immunologically active cells by one of the
major metabolites of levamisole, O.M.P.I., hence increasing the rate of multiplication of the 
parasites.
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Single and combined treatments of levamisole, vitamin E and synthetic antioxidants 
have no significant effect on adult Nematosoiroides dubius in mice. Levamisole at a dose 
rate of 2.5 mg/kg body weight used in the present study had no anthelmintic effect and did 
not exhibit any synergistic effect with vit.E and synthetic antioxidants. Investigations 
reported by Smith and Bryant (1986) also suggest that N.dubius are more resistant to 
damage caused by free radicals produced by the host immune system because of the 
presence of higher levels of activity of protective enzymes compared to Nippostrongylus 
brasiliensis.
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CHAPTER - 6 Combined treatment of antioxidant, levamisoie and mebendazole.
6.1 General
Considering the suggestions of Chevis and Bryant (personal communication) that the 
synergistic effect of vitamin E and levamisoie with benzimidazoles is due to their capacity 
for scavenging free radicals, an attempt was made in these experiments to study whether 
the synthetic antioxidants could replace vit.E and levamisoie. The synergy reported by 
Bennet et. al..(19761 between mebendazole and levamisoie, was also studied in different 
strains of mice.
6.2 Methods 
Experiment 6.1.1.
Groups of five mice infected with twenty M.corti larvae each were treated with 
vitamin E, BHA, levamisoie and mebendazole alone or in combination. The treatment 
started from day 1 post infection and continued for five days. From day 6 post infection, 
all groups of mice were given control feed and water and the animals were killed on day 16 
post infection and the larvae were recovered.
Experiment 6.1.2.
The above experiment was repeated in CBA male mice.
Experiment: 6.1.3 & 6.1.4.
Experiment 6.1.1 was repeated replacing BHA with DPPD in QB and CBA males in ex­
periments 6.1.3 & 6.1.4 respectively.
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Experiment 6.1.5.
In this experiment, five different strains of mice were used to study the proposed 
synergy between mebendazole and levamisole. Male mice of QB, CBA, Swiss, Balb C and 
C57 were infected with 20 M.corti each and treated with mebendazole and/or levamisole 
for the first five days of infection. The mice were fed with control feed from day 6 to day 
15 post infection and killed on day 16 and the parasites were recovered and counted.
Nematosoiroides dubius
Experiment 6.2.1.
Groups of 5 Quackenbush female mice were infected each with 100 third stage larvae 
of N.dubius. Treatment with mebendazole, vitamin E, BHA and levamisole alone or in 
combination was started from day 14 and continued for six days. All the groups of mice 
were kept on control diet for a further period of 10 days and the mice were killed and sur­
viving worms were recovered from the intestines of the host. During the treatment period, 
faecal samples were collected daily and examined for egg production. The eggs were also 
cultured and the percentage of embryonated eggs was determined .
Experiment 6.2.2.
Experiment 6.2.1 was repeated with the synthetic antioxidant DPPD replacing BHA.
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6.3 Results
Experiment 6.1.1 & 6.2.2.
The results are presented in fig. 6.a (Table-6.1) and 6.b (Table-6.2) for the parasites 
recovered from peritoneal cavities and livers of Quackenbush and CBA male mice respec­
tively. The average number of parasites recovered per mouse was plotted against the treat­
ment group.
There is a seven to eight times multiplication of the larvae in the control group of 
Quackenbush and CBA mice. Single treatments of vitamin E, BHA and levamisole appear to 
increase the parasite numbers in peritoneal cavities and livers of both strains of mice but 
the difference was not statistically significant at this stage of infection. Five days treat­
ment with mebendazole stopped the multiplication of the larvae. Mebendazole in combina­
tion with BHA or vitamin E had no significant effect on the number of parasites compared 
to single treatments of mebendazole in both the strains of mice used. When mebendazole 
was administered together with levamisole, a significantly lower number (Pc.Ol & .05 in 
peritoneal cavities and livers respectively) of parasites was recovered in Quackenbush male 
mice but not in CBA males. Mebendazole in combination with levamisole exhibited a syner­
gistic effect only in Quackenbush male mice either in the presence or absence of an­
tioxidants.
Experiment 6.1.3 & 6.1.4.
The results are presented in fig. 6.c (Table-6.3) and 6.d (Table-6.4) for parasites 
recovered from peritoneal cavities and livers of Quackenbush and CBA male mice respec­
tively. The average number of parasites recovered was plotted against the treatment groups.
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Figure 6.a
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of QB male 
mice following treatment with vitamin E, BHA, 
levamisole and mebendazole on its own or in 
combination.
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Figure 6.b
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of CBA male 
mice following treatment with vitamin Ef BHA, 
levamisole and mebendazole on its own or in 
combination.
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Figure 6.c
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of QB male 
mice following treatment with vitamin E, DPPD, 
levamisole and mebendazole on its own or in 
combination.
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Figure 6.d
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of CBA male 
mice following treatment with vitamin E, DPPD, 
levamisole and mebendazole on its own or in
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Fig. 6.d
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There was a 9 to 10 fold increase in the parasite numbers in Quackenbush male control 
mice whereas the increase was 10 to 12 fold in CBA males. Single treatments of an­
tioxidants and levamisole had no significant effect on the parasite numbers as compared to 
the controls in both the strains of mice. Mebendazole treatment for 5 days caused the death 
of 50 and 60% of parasites from initial inoculation in Quackenbush and CBA mice respec­
tively. Mebendazole in combination with antioxidants had no significant effect compared 
to mebendazole treatment alone in Quackenbush mice whereas similar treatment increased 
the larval recovery in CBA males significantly as compared to mebendazole treatment 
alone. In Quackenbush males, a significantly decreased numbers of parasites was recovered 
when mebendazole was combined with levamisole either in the presence or absence of an­
tioxidants. No such synergy was observed between mebendazole and levamisole in CBA 
males.
Experiment 6.1.5.
The results are presented in fig. 6.e. (Table-6.5.),6.f. (Table- 6.6.), 6.g. (Table-6.7.), 6.h. 
(Table-6.8.), and 6.i (Tables- 6.9.) for QB, CBA, Swiss white, Balb C and C57 mice respec­
tively.
Strain variation in the rate of multiplication of larvae was discussed in chapter 3. 
Mebendazole treatment for 5 days caused the death of 70 to 75% of the larvae from initial 
inoculation in all five strains of mice used in the present experiment. The number of 
parasites recovered from the combined treatment of mebendazole and levamisole was not 
significantly different from the single treatment of mebendazole in C57, Balb C and Swiss 
male mice. Mebendazole in conjunction with levamisole has significantly decreased the 
parasite numbers in Quackenbush male mice, whereas a significantly increased number of 
parasites were recovered from the peritoneal cavities and livers of CBA male mice com­
pared to the single treatment of mebendazole.
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Figure 6.e
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of QB male 
mice following treatment with mebendazole and/ 
or levamisole.
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Figure 6.f
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of CBA male 
mice following treatment with mebendazole and/or 
levamisole.
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Figure 6.g
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of male 
Swiss White mice following treatment with 
mebendazole and/or levamisole.
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Figure 6.h
Tetyrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of male 
Balb C mice following treatment with 
mebendazole and/or levamisole.
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Figure 6.i
Tetrathyridia of Mesocestoides corti recovered 
from peritoneal cavities and livers of male 
C57 mice following treatment with mebendazole 
and/or levamisole.
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Food and water intake by the five strains of mice used in this experiment was measured 
during the experimental period using the experimental design described in chapter-2. 
Results are presented in Table- 6.10 & 6.11 for food and water intake respectively. No sig­
nificant difference in the food consumption and liquid intake of treatment groups com­
pared to controls was apparent in the five strains of mice used in the present study.
Experiment 6.2.1.
The results are presented in fig. 6.j, and 6.k (Table - 6.12) for the average number of 
eggs per gram of faeces, and percentage of embryonated eggs respectively.
Single treatments of vitamin E, levamisole and BHA had no significant effect on the 
egg production by the adult worms. Mebendazole treatment has caused the disappearance of 
eggs from the faeces after 5 days of treatment. Mebendazole in combination with 
levamisole was effective in removing the eggs from the faeces after 4 days of treatment. 
Mebendazole together with levamisole and vitamin E was further more effective in remov­
ing the eggs from the faeces only after 2 days of treatment. However, mebendazole in com­
bination with BHA had no significant effect and the egg production continued even after 6 
days of treatment.BHA together with mebendazole had significantly reduced the ovicidal 
effect of mebendazole and 80% of the eggs were embryonated after 5 days of treatment.
Similar results were observed on the number of surviving worms after the treatment. 
Single treatments of antioxidants and levamisole had no significant effect on the number 
of surviving worms. Mebendazole treatment alone and in combination with levamisole and 
or vitamin E completely removed the parasites from the intestine of the host. Mebendazole 
when combined with BHA had no effect on the survival of the adult worms and the num-
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Fig. -  6.j
QB Female mice infected with Nematospiroides dubius 
and treated with Vitamin E, BHA, Levamisole and 
Mebendazole on its own or in combination 
Average number of eggs produced per gram of faeces
Treatment Groups:
A Control
B : Vitamin E
C Levamisole
D : BHA
E Mebendazole + BHA
F : Mebendazole
G Mebendazole + Vitamin E + BHA
H Mebendazole + Vitamin E + Levamisole + BHA
I Mebendazole + Levamisole
J Mebendazole + Vitamin E
K Mebendazole + Levamisole + Vitamin E
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Fig. - 6.k
QB Female mice infected with Nematospiroides dubius 
and treated with Vitamin E, BHA, Levamisole and 
Mebendazole on its own or in combination 
Percentage of eggs hatched
Treatment Groups:
A Control 
B : Vitamin E 
C : Levamisole 
D : BHA
E Mebendazole + BHA
F : Mebendazole + Vitamin E + Levamisole + BHA 
G Mebendazole + Vitamin E + BHA 
H Mebendazole 
I Mebendazole + Levamisole
J Mebendazole + Vitamin E
K Mebendazole + Levamisole + Vitamin E
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ber of parasites recovered was not significantly different from the control group. Meben­
dazole and BHA when combined with vitamin E and/or levamisole, removed 48.8 and 25.8 
% of the worms respectively.
Experiment 6.2.2.
Similar results were observed when BHA was replaced by DPPD. Fig 6.1 and 6.m. (Table 
- 6.13) represent the number of eggs per gram of faeces and the percentage of eggs hatched 
respectively. Single treatments of antioxidants and levamisole have no significant effect on 
the egg production by the adult worms and exhibited no ovicidal effect. The number of 
surviving worms recovered was also not significantly different from the control group. 
MBZ alone or in combination with vitamin E and/or DPPD has caused the disappearance 
of eggs from the faeces after 4 days of treatment. MBZ when combined with levamisole 
was effective in abolishing the egg production after 3 days of treatment. MBZ together 
with vitamin E and levamisole was more effective and the eggs disappeared from the 
faeces after only 2 days of treatment. Single and combined treatments of MBZ had com­
pletely removed the infection and no surviving worms were recovered after 5 days of 
treatment.
The results of the above experiments are summarised below.
I. Mesocestoides corti.
1. Mebendazole administration at a dose rate of 50 mg/kg feed for 5 days kills 45 to 75 
% of the larvae from initial inoculation in different strains of mice used in the study.
2. No synergistic effect was observed when MBZ was combined with vitamin E and syn­
thetic antioxidants.
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Fig. -  6.1
QB Female mice infected with Nematospiroides dubius 
and treated with Vitamin E, DPPD, Levamisole 
Mebendazole on its own or in combination 
Average number of eggs produced per gram of faeces
Treatment Groups:
A Control 
B Mebendazole 
C : Levamisole 
D Vitamin E 
E : DPPD
F Mebendazole + Vitamin E 
G Mebendazole + DPPD 
H Mebendazole + Levamisole 
I Mebendazole + DPPD + Vitamin E 
J : Mebendazole 4-  Levamisole + Vitamin E 
K Mebendazole + Levamisole + DPPD + Vitamin E
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Fig. -  6.m
QB Female mice infected with Nematospiroides dubius 
and treated w ith Vitam in E, DPPD, Levamisole 
and Mebendazole on its own or in combination 
Percentage of eggs hatched
Treatm ent Groups:
A • Control
B : Levamisole
C ; Vitam in E
D • DPPD
E ; Mebendazole
F : Mebendazole + DPPD
G • Mebendazole + Vitam in E
H •• Mebendazole + Levamisole
I Mebendazole + Vitam in E + DPPD
J : Mebendazole + Levamisole + Vitam in E
K : Mebendazole + Levamisole + DPPD + Vitam in E
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3. The synergy between mebendazole and levamisole, reported by Bennet et al.. (1976) 
was observed only in Quackenbush male mice, but not in the other strains of mice used in 
the present study. (CBA, Swiss white, Balb C & C57).
4. Synthetic antioxidants in conjuction with MBZ protect the parasites and the number 
of larvae recovered was significantly increased when compared to MBZ treatment alone in 
CBA males.
II. Nematospiroides dubius.
1. MBZ at a dose rate of 100 mg/kg feed was effective in removing N.dubius infection 
in 5 days.
2. MBZ in combination with levamisole was effective in removing the parasites after 4 
days of treatment.
3. Vit.E and synthetic antioxidants had no synergistic effect when combined with MBZ. 
BHA when combined with MBZ, reduced the ovicidal and anthelmintic effect of MBZ and 
surviving worms were recovered even after 6 days of treatment.
6.4 DISCUSSION
No significant variation in the rate of multiplication of M.corti was observed between 
QB and CBA males at 15 days post infection. Strain variation in the rate of multiplication
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of the larvae was significant only after 20 days post infection.
For the existence of a major synergistic effect, parasite numbers would have to be sig­
nificantly reduced or completely eliminated from the host. Such an effect was observed be­
tween MBZ and levamisole in Quackenbush mice infected with M.corti and N.dubius. 
which confirms the studies reported by Bennet et al.. (1976). These investigators suggested 
that levamisole may be acting through the immune system of the host in synergising with 
MBZ. This synergistic effect was not observed when infected mice were pre-treated with 
levamisole and also when mice are irradiated before the treatment. The evidence presented 
that levamisole acts through the immune system to achieve synergy with MBZ is thus cir­
cumstantial. No such synergy was observed in the other strains of mice used in the present 
study. Levamisole may be acting through the immune system of the host in synergising 
with mebendazole, but this is subject to variation according to the strain of mice, due to 
variation in the pharmakokinetics of the drugs,etc. It is also possible that levamisole acts 
by increasing the solubility of mebendazole and/or increasing the absorption of meben­
dazole by the host, since it is more soluble in water compared to mebendazole.
No such synergy was observed when mebendazole was used in conjuction with the an­
tioxidants vitamin E., BHA and DPPD. On the other hand, antioxidants when used together 
with mebedazole increased the larval recovery in CBA male mice compared to mebendazole 
treatment alone. The circumstantial evidence presented in these experiments again suggests 
that the synergising capacity of levamisole is not just due to its capacity for scavenging 
free radicals.
Similar results were observed when mice infected with N.dubius were treated similarly 
with mebendazole alone or in combination with levamisole and antioxidants. BHA treat­
ment together with mebendazole reduced the ovicidal and anthelmintic effect of meben-
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CHAPTER - 7
General Discussion & Future work
Oral administration of levamisole and anti-oxidants to mice infected with tetrathyridia 
of Mesocestoides corti increases their rate of multiplication significantly as compared to 
controls. Since the effect displayed by levamisole was also observed with vitamin E and 
other synthetic antioxidants, it is probable that free radicals produced by the host immune 
system play a significant role in M.corti infection. The immunological response to M.corti 
includes both cellular and humoral components. Neither humoral nor cell-mediated im­
munity is effective in eliminating the infection in mice. The partial protection of the host 
expressed as a reduced proliferative rate, is T-cell dependant. It is possible that free radi­
cals produced by the host immune system play a significant role in cell-mediated im­
munity in M.corti infection.
Oxygen metabolites in biological systems are known to have two contradictory roles, as 
positive mediators in proinflamatory responsesand also as immunosuppressants by causing 
tissue damage. As postive mediators, they are known to generate chemotactic response 
through the generation of chemotactic factors (Perez & Goldstein, 1980), and activate T- 
lymphocytes as positive mediators, so that their removal suppresses T-cell proliferation at 
some stage prior to the expression of Interluekin-2 receptors (Chcatfdhri et al.,1986). They 
can also cause tissue injury by augmenting inflammatory response by the inactivation of 
normal serum inhibitors of leukocyte protease, thereby causing distruction of the structural 
components of tissue (Crap & Janoff, 1979), or by directly altering structural components 
of tissue (McCord, 1974). This means that oxygen metabolites either by themselves or in 
conjunction with lysosomal proteases can injure the structural matrix of tissues, which may 
be one of the reasons for immunosuppression in parasitic infections. The precise in vivo ef­
fects of oxygen metabolites on biological substrates is not yet clear.
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To understand the role of free radicals in mice infected with M.corti. it is essential to
carry out further investigations to confirm the production of free radicals by immunocom­
petent cells. Oxygen derived metabolites may play a significant role in tissue injury during 
the early period of macrophage activation. Hence, future investigations should be directed 
at measuring these metabolites at different stages of infection and understanding their 
mechanism of action in mice infected with M.corti.
Recent investigations by Chevis and Bryant (personal communication) suggest that im­
munosuppression in mice infected with M.corti is mediated by free radicals produced by 
macrophages. In vitro studies of lymphocyte populationswith peritoneal exudate cells from 
mice infected with M.corti will be helpful in understanding the suppression of lymphocyte 
proliferation by activated macrophages. Catalase, which eliminates, specifically, the 
hydrogen peroxide produced by activated macrophages, when added to in vitro cultures of 
peritoneal exudate cells, will allow us to evaluate the possible role of hydrogen peroxide in 
macrophage induced suppression. A comparative study of the estim ation of im ­
munoglobulins and antibody titres, between infected mice, treated with free radical 
scavengers and that of untreated groups will be helpful in understanding the role of free 
radicals and will also be able to explain the immunosuppression in mice infected with 
M.corti.
Similar treatment with levamisole and antioxidants had no significant effect on the egg 
production or survival of adult Nematospiroides dubius. A dose rate of 2.5 mg/kg body 
weight used in the present study had no anthelmintic effect on N.dubius. Investigations 
reported by Smith & Bryant (1986) also suggest that N.dubius are resistant to damage 
caused by free radicals produced by the host immune system because of the presence of 
o> higher proportion of protective enzymes compared to Nippostronevlus brasiliensis.
Oral administration of mebendazole to infected mice is effective in removing M.corti 
infection which confirms the studies reported by Heath et al.. (1975) and Bennet et al.. 
(1976). The minimum dose of mebendazole that can be effectively  used against
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tetrathyridia is 50 mg/kg of feed. Levamisole in combination with mebendazole exhibited 
synergistic effect only in QB mice, but not in other inbred and outbred strains of mice 
used in the present study. However, the synergistic studies in different strains of mice were 
carried out only once and need further confirmation. If confirmed, this variation could be 
due to differences in the pharmacokinetics of the drugs. The synergistic effect observed in 
QB male mice infected with M.corti and in N.dubius infections could be due to stimulation
fa t
o fAhost immune system by levamisole as reported by Bennet et al (1976), using athymic
&mice. To confirm the existence of synergy, future investigations should be directed at 
estim ating the plasma concentration of mebendazole in both mnebendazole and 
mebendazole and levamisole treatment groups, in different species of animals.
No synergy was observed when mebendazole was administered together with vit.E and 
other synthetic antioxidants. BHA when used in conjunction with mebendazole reduces the 
anthelmintic effect of mebendazole probably by inducing detoxifying enzymes. Further 
studies should be directed at determining the activities of enzymes in the livers and many 
extrahepatic tissues of rodents with supplemented dietary BHA and other antioxidants.
Thus, the evidence reported here is mostly circumstantial, but opens many new paths for 
future work for better understanding of the pharmaco-kinetics of the drugs.
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Pyrantal pamoate 
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Dichlorophen 
Phenasol 
- 
98% 
Taenia saginata 
Grinenko, 
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Combination treatment against Helminth parasites in Dog
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Combination treatment against Helminth parasite in Poultry
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Table -4.1
The effect of oral administration of different dose rates of 
mebendazole to mice infected with 20 tetrathyridia of
Mesocestoides corti.
Amount of mebendazole consumed in mg/Mouse/Day
Dose rate of mebendazole in mg/kg feed
INO» ui days 
none 25 50 100 150 200
i 0.095 0.190 0.410 0.555 0.700
2 0.093 0.150 0.380 0.645 0.740
3 0.105 0.215 0.310 0.480 0.900
4 0.102 0.250 0.290 0.450 1.000
5 0.075 0.180 0.380 0.585 0.720
Mean mebendazoleconsumed in mg/ 0.094+ 0.197+ 0.354+ 0.543+ 0.812+Mouse/Day + S.D.
0.01 0.03 0.04 0.07 0.11
Mean number of 
larvae reco­
vered after 29.50 31.00 9.50 4.00 0 05 days Of MBZ 
treatment + S.E. 2.80 7.40 4.40 1.90
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Table - 4.2
Mebendazole dose response in QB female mice infected 
with Nematosoiroides dubius
Day
Amount of Mebendazole in mg/kg feed
NONE 2 4 6 8
0 35,050 36,775 25,950 40,800 18,575
1 46,700 56,225 39,425 42,300 31,475
2 34,500 42,500 33,037 44,450 32,562
3 21,925 38,025 30,155 25,612 37,560
4 30,875 26,925 20,150 36,950 40,675
5 18,900 19,000 19,825 27,150 31,975
6 27,725 20,986 16,700 47,125 27,550
7 49,375 28,425 24,675 38,925 19,400
8 36,075 42,575 36,125 34,500 23,200
9 35,725 36,050 41,850 35,450 25,125
Egg hatch assay
Percentage of eggs hatched
0 97.64 97.14 96.62 98.82 97.80
2 98.20 94.80 93.80 92.20 93.80
4 96.00 97.10 95.10 97.30 97.40
6 61.00 93.10 93.00 86.60 96.40
8 96.50 98.50 85.00 98.50 89.50
10 98.50 97.50 92.50 92.60 98.20
(Contd.)
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Amount of mebendazole consumed in mg/Mouse/Day
1 0 0.007 0.015 0.021 0.030
2 0 0.008 0.018 0.016 0.024
3 0 0.009 0.021 0.027 0.031
4 0 0.010 0.023 0.027 0.034
5 0 0.007 0.015 0.020 0.024
6 0 0.007 0.012 0.018 0.036
7 0 0.006 0.016 0.021 0.032
Mean number of surviving worms recovered from each treatment
group + Standard Error
39.50 + 40.66 + 45.00 + 43.20 + 38.50 +
2.30 4.81 3.50 4.15 3.30
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Table - 4.3
Mebendazole dose response in QB female mice infected 
with Nematosoiroides dubius 
Average No. of eggs/gram of faeces
Amount of MBZ in mg/kg feed
Day
NONE 10 15 20 25
0 16,300 11,600 6,725 14,900 10,175
1 8,875 21,050 10,650 19,525 17,750
2 11,825 25,250 10,950 19,225 9,750
3 20,250 22,775 18,175 21,700 12,335
4 24,850 19,575 14,512 16,500 17,125
5 20,150 20,825 12,210 6,675 11,275
6 11,525 21,925 8,000 7,375 8,925
7 10,300 17,100 7,650 10,575 10,950
8 13,850 13,025 5,750 7,375 9,400
Egg Hatch Assay
Day Percentage of eggs hatched
0 93.5 94.6 97.8 91.3 95.9
2 90.2 73.3 53.6 58.8 64.4
3 96.7 73.9 55.6 45.0 17.2
6 98.7 95.3 36.0 22.7 27.3
8 94.6 82.3 37.0 30.2 33.2
(Contd.)
161
Amount of MBZ consumed on average in mg./mouse/day
1 0.00 0.039 0.052 0.074 0.092
2 0.00 0.046 0.042 0.060 0.087
3 0.00 0.054 0.067 0.078 0.080
4 0.00 0.058 0.067 0.086 0.100
5 0.00 0.039 0.052 0.060 0.070
6 0.00 0.038 0.057 0.062 0.080
Mean number of surviving worms recovered after treatment
+ Standard Error.
44.50 + 48.60 + 44.57 + 42.50 + 47.70 +
3.80 4.83 4.51 3.90 4.16
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Table- 4.4
Mebendazole dose response in QB female mice infected with
Nematospiroides dubius 
Average number of eggs per gram of faeces
Day Amount of MBZ in mg/kg feed
0 NONE 50 100 150 200
0 9,950 28,975 9,000 12,900 6,900
1 22,650 19,100 14,387 6,750 3,725
2 44,400 33,900 8,625 4,250 2,975
3 21,600 17,450 5,950 3,500 825
4 20,850 19,725 4,125 2,900 350
5 39,000 12,075 3,150 1,375 100
6 28,200 8,550 2,250 900 0
7 18,800 3,500 1,150 250 0
Egg hatch assay
Percentage of eggs hatched
0
2
4
6
97.8
95.9 
99.4 
94.1
93.1
45.9
14.3
5.7
96.6
3.3
0
0
96.8
0
0
0
96.5
0
0
0
(Contd.)
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Average amount of MBZ consumed in mg ./mouse/day•
0 0.00 0.12 0.28 0.37 0.42
1 0.00 0.13 0.29 0.36 0.62
2 0.00 0.16 0.30 0.42 0.60
3 0.00 0.16 0.35 0.45 0.88
4 0.00 0.19 0.37 0.52 0.70
5 0.00 0.17 0.38 0.54 0.98
6 0.00 0.19 0.38 0.57 0.98
7 0.00 0.19 0.42 0.60 0.94
Mean number of worms recovered following the treatment +
Standard Error
48.40 + 49.20 + 6.40 + 3.80 + 1.00
2.27 3.40 1.73 1.51 0.50
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Table - 4.5
QB female mice infected with Nematospiroides dubius and
treated with levamisole
Average number of eggs produced per gram of faeces
Day
Levamisole in mg/kg body weight
None 2.5 5.0
0 8,525 12,550 7,625
1 9,500 9,650 6,875
2 7,200 8,850 5,625
3 8,350 7,850 4,900
4 6,625 9,950 5,050
5 10,525 10,250 8,525
6 11,500 11,750 9,200
7 12,175 10,650 5,825
8 10,825 9,875 4,875
Number of surviving worms recovered after treatment
Mean 41.33 42.66 18.33
Standard Error 5.50 3.46 3.29
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Table - 4.6
Tetrathyridia of Mesocestoides corti recovered from the 
peritoneal cavities and livers of QB male mice following the 
treatment with different dose rates of Vitamin - E.
Number of parasites recovered
Vit.E in -----------------------------------------------
mg./kg. feed Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
None 74.00 8.51 67.60 9.51 141.60 11.80
200 105.00*** 7.65 138.20**** 28.72 243.20 31.20
400 81.60** 11.34 98.20* 11.45 159.80 11.45
800 91.20** 11.38 96.80* 10.40 178.00 18.79
1,600 92.60** 7.10 110.80*** 7.10 215.40 7.65
3,200 96.40** 4.40 103.80** 9.80 200.20 11.16
6,400 106.00*** 4.30 99.00**** 2.29 205.00 3.70
12,800 81.40 3.94 83.80 10.42 165.20 11.31
* : P < 0.05
** : P < 0.025
*** : P < 0.005
**** ; p < o.Ol
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Table -4.7
Liver and spleen weights from mice infected with tetrathridia 
of Mesocestoides corti and treated with different dose rates
of Vitamin E.
Dose rate in Number of Weight in grams
mg/kg feed animals in Liver Spleen
each group
Mean Standard Mean Standard
Error Error
None 5 1.78 0.04 0.21 0.01
200 5 2.23* 0.15 0.26 0.04
400 5 2.32*** 0.07 0.34*** 0.02
800 5 2.50** 0.07 0.33*** 0.02
1,600 5 2.38** 0.16 0.36* 0.08
3,200 5 2.54* 0.20 0.31* 0.02
6,400 5 2.90*** 0.04 0.315*** 0.01
12,800 5 1.93 0.06 0.203 0.01
* : P < 0.05 *** ; p < 0.005
** : P < 0.01 **** ; p < 0.001
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Table - 4.8
Tetrathyridia of Mesocestoides corti recovered from the 
peritoneal cavities and livers of QB male mice following 
treatment with different dose rates of 
N, N '-Diphenyl-P-Phenylene diamine
Dose rate No. of Number of parasites recovered
in animals ----------- --------------------------
feed in each Peritoneal Livers Total
group Cavity
Mean Standard Mean Standard Mean Standard
Error Error Error
None 6 86.00 1.64 93.80 4.56 159.80 5.13
400 6 142.40** 16.59 247.40*** 28.79 387.80 41.89
800 6 135.60** 17.89 177.75* 24.75 277.80 29.90
1,600 6 133.60** 18.94 170.60* 24.37 304.20 32.11
3,200 6 143.16** 16.70 151.83* 18.04 265.00 27.20
6,400 6 134.83** 16.71 151.20* 14.32 265.40 31.57
12,800 6 132.20** 14.64 199.20* 35.62 331.40 47.41
* : P <0.01
** : P <0.005
*** : P <0.001
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Table - 4.9
Liver and Spleen weights from mice infected with tetrathyridia 
of Mesocestoides corti and treated with different dose rates 
of N, N '-Diphenyl-P-Phenylenediamine
Dose rate in 
mg/kg feed
Number of 
animals in 
each group
Me
Weight in grams
Liver Spleen
an Standard Error Mean Standard Error
None 6 1.462 0.05 0.270 0.02
400 6 1.884* 0.15 0.240 0.02
800 6 1.836* 0.12 0.245 0.03
1,600 6 1.919*** 0.11 0.225 0.02
3,200 6 2.509*** 0.17 0.292 0.02
6,400 6 2.208***** 0.12 0.262 0.03
12,800 6 2.269* 0.20 0.307 0.02
* : P < 0.05
** : P < 0.01
*** : P < 0.005
**** : P < 0.001
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Table - 4.10
Number of tetrathyridia in the peritoneal cavity and liver of 
three inbred (CBA, BALB/c & C57) and two outbred (QB & Swiss) 
strains of mice at 20 days post-infection, following 
intraperitoneal inoculation.
No. of parasites recovered 
Peritoneal Liver Total
cavities
Strain Sex Mean Standard
Error
Mean Standard
Error
Mean Standard 
Error
QB Male 101.33 3.00 98.33 10.13 199.67 13.10
QB Female 99.50 8.95 63.83 14.36 163.33 8.50
Swiss Male 159.80 10.32 219.20 35.80 379.00 41.10
CBA Male 209.71 20.89 192.42 38.30 402.14 36.20
CBA Female 182.00 31.00 49.60 14.70 231.40 35.00
C57 Male 101.80 8.40 86.60 3.50 188.40 7.00
Balb/c Male 134.00 11.10 150.20 11.20 264.20 24.20
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Table - 5.1
Tetrathyridia of Mesocestoides corti recovered from Peritoneal 
cavities and Livers of QB male mice following treatment with 
Levamisole, BHA and Vitamin E on its own or in combination
Number of parasites recovered
Treatment groups -----------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Controls 101.33 3.00 98.33 10.13 199.67 12.5
BHA 110.30 3.55 121.00 6.70 231.00 8.7
Vitamin E 112.33 3.00 125.57 34.33 257.67 35.2
Levamisole 117.50 3.23 148.43 7.46 266.00 7.1
BHA+Levamisole 141.17 11.13 183.60 24.79 345.00 30.0
Vitamin E+Levamisole 159.71 5.15 180.50 3.50 340.00 9.8
BHA+Vitamin E 187.33 3.14 163.00 12.82 339.50 7.5
Vit.E+BHA+Levamisole 162.20 11.96 145.50 20.93 278.40 6.1
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Table - 5.2
Tetrathyridia of Mesocestoides corti recovered from Peritoneal 
cavities and Livers of QB female mice following treatment with 
Vitamin E, BHA and Levamisole on its own or in combination
Number of parasites recovered
Treatment Groups -------------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Controls 99.50 8.95 63.83 14.36 163.33 9.10
BHA 83.20 17.57 182.00 53.77 265.00 65.00
Vitamin E 137.00 10.62 110.33 14.93 227.20 11.60
Levamisole 106.80 9.98 109.00 24.02 226.60 33.50
BHA+Levamisole 124.28 7.0 143.33 12.50 261.31 8.20
Vitamin E + Lev 116.28 15.30 147.80 6.93 249.03 19.40
BHA+vitamin E 144.30 16.90 187.83 63.84 282.17 35.20
Vit.E+BHA + Lev 83.00 12.13 94.80 23.72 206.60 22.80
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Table - 5.3
Tetrathyridia of Mesocestoides corti recovered from Peritoneal 
cavities and livers of CBA male mice following treatment with 
Vitamin E, BHA and levamisole on its own or in combination
Number of parasites recovered
Treatment groups -------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard 
Error Error Error
Controls 209.71 20.89 192.42 38.30 402.14 47.50
BHA 210.83 33.74 291.16 28.34 502.00 27.20
Vitamin E 308.83 27.79 335.16 60.44 674.50 67.80
Levamisole 316.28 35.88 218.28 29.28 534.57 61.40
BHA+Levamisole 248.83 9.19 248.50 54.00 497.33 62.30
Vitamin E + Lev. 224.83 38.78 234.50 34.70 359.33 63.10
BHA+Vitamin E 334.16 3.10 338.33 38.85 692.50 31.70
Vit.E+BHA+Lev. 256.50 21.80 310.50 52.08 567.00 61.84
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Table - 5.4
Tetrathyridia of Mesocestoides corti recovered from Peritoneal 
cavities and livers of CBA female mice following treatment 
with Vitamin E, Levamisole and BHA 
on its own or in combination.
Number of parasites recovered
Treatment Groups ------------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Controls 182.00 31.22 99.00 14.10 231.40 35.30
BHA 171.17 9.00 215.50 53.70 386.67 61.80
Vitamin E 225.00 19.37 175.60 26.26 400.60 28.20
Levamisole 187.40 11.32 146.00 7.30 333.40 39.20
BHA+Levamisole 204.60 18.52 120.80 7.30 325.60 28.50
Vitamin E+Leva- 
misole
192.60 38.70 142.60 13.13 235.00 38.70
BHA+Vitamin E 299.60 50.00 269.40 53.69 575.00 54.70
Vit.E+Levamisole 
+ BHA
187.20 16.20 176.40 21.87 363.60 21.90
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Table - 5.5
Tetrathyridia of Mesocestoides corti recovered from Peritoneal 
cavities and livers of QB male mice following treatment with 
Vitamin E, DPPD and Levamisole on its own or in combination
Number of parasites recovered
Treatment Groups ------------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Controls 86.00 10.25 61.80 17.89 148.20 19.10
DPPD 149.50 15.27 147.60 5.16 399.60 60.40
Vitamin E 137.60 8.71 126.20 1.24 303.80 11.9
Levamisole 167.40 14.21 148.00 29.16 315.40 29.50
Vitamin E+DPPD 129.33 18.44 191.00 25.57 331.00 28.50
DPPD+Levamisole 138.40 16.25 112.20 18.26 270.60 26.30
Vit.E+Levamisole 102.60 8.12 152.40 31.40 295.00 25.70
Vit.E+DPPD+Lev. 142.00 11.88 179.50 28.66 321.50 35.00
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Table - 5.6
Tetrathyridia of Mesocestoides corti recovered from peritoneal 
cavities and livers of CBA male mice following treatment with 
Vitamin E, DPPD and Levamisole on its own or in combination
Number of parasites recovered
Treatment Groups ----------------------------------------
Peritoneal Livers Total
Cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Controls 111.60 23.71 108.80 26.15 230.40 35.30
DPPD 152.86 13.17 176.86 22.15 329.57 32.70
Vitamin E 122.40 15.58 197.60 15.83 220.60 13.20
Levamisole 164.00 9.96 141.20 7.86 305.20 11.50
Vitamin E+DPPD 134.43 20.89 164.00 12.14 241.00 30.00
DPPD+Levamisole 162.50 17.10 90.80 16.59 260.40 19.50
Vitamin E+Lev. 145.57 11.67 115.00 18.11 259.60 12.50
Vitamin E+Lev.+ 
DPPD.
132.00 10.95 110.14 7.51 147.29 20.10
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Table -5.7
The mean area of leukocyte invasion in millimeters around 5 
tetrathyridia of Mesocestoides corti from each 
treatment group
Treatment Group Leukocyte
Mean
area/parasite 
Standard Error
Level of sig­
nificance 
from controls P <
Control 0.242 0.012
Vitamin E 0.320 0.030 -
Levamisole 0.625 0.044 0.001
BHA 0.231 0.016 -
Vit.E + Lev. 0.490 0.050 0.01
BHA + Lev. 0.233 0.015 -
BHA + Vit.E 0.210 0.015 -
Vit E + BHA + Lev. 0.450 0.035 0.01
177
Table - 5.8
Food intake by QB male mice infected with tetrathyridia of 
Mesocestoides corti and treated with antioxidants and
levamisole
Food intake in grams/day/mouse
Mean food 
consumed/ 
day/MouseTreatment
Groups
Day-1 Day-2 Day-3 Day-4 Day-5 Day-6 Day-7 Mean+S.D.
Control 4.5 5.2 3.1 3.7 3.3 4.2 4.7 4.10+0.71
Levamisole 4.0 4.4 3.2 3.8 4.0 4.4 3.8 3.94+0.38
BHA 4.5 5.8 4.7 4.0 4.2 5.1 5.8 4.87+0.67
Vitamin E 4.3 4.6 3.2 3.8 4.0 4.7 3.8 4.05+0.48
BHA+ Vit.E 4.8 4.0 5.3 5.7 5.2 5.4 3.2 4.80+0.82
BHA + Lev. 3.0 3.3 4.8 4.3 5.2 4.7 4.4 4.24+0.74
Vit.E+Lev. 5.4 6.1 5.1 4.2 4.5 4.6 5.2 5.01+0.59
Vit.E+Lev+ 
BHA
3.0 4.1 4.8 6.2 4.1 4.5 3.8 4.35+0.91
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Table - 5.9
Liquid intake of mice treated with levamisole and/or an 
tioxidants compared to untreated mice
Liquid intake /Mouse/Day (mis) Mean
water
Treatment consumed/
Group
Day-1 Day-2 Day-3 Day-4 Day-5 Day-6 Day-7 day + S.D
Control 5.6 6.0 5.5 5.9 5.3 5.8 6.0 5.72+0.24
Levamisole 6.2 6.4 5.8 7.0 6.0 6.1 6.3 6.25+0.35
Vit.E+Lev. 5.2 5.3 6.5 6.0 6.2 5.1 5.0 5.65+0.55
BHA+Lev. 6.0 6.2 5.7 5.6 5.0 5.3 6.8 5.80+0.55
BHA+Vit.E 4.8 5.8 6.0 6.2 5.9 5.0 6.3 5.71+0.54
+Lev.
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Table - 5.10
QB Female mice infected with Nematospiroides dubius and 
treated with Vit. E, Levamisole and BHA on its own or in
combination
Average Number of Eggs produced per gram of Faeces
Treatment Groups
Day None BHA Vit.E Leva­
misole
BHA+
Vit.E
BHA+ Vit.E BHA+Vit.E 
Lev. +Lev. +Lev.
0 9,525 8,725 8,225 7,625 10,500 8,650 9,950 9,250
1 8,200 7,900 6,250 6,875 9,300 7,900 8,050 11,300
2 8,325 6,200 7,350 6,625 9,625 11,550 5,475 13,650
3 7,600 6,450 7,525 6,900 12,175 11,800 8,80 18,525
4 8,625 8,375 6,150 5,050 14,525 13,425 8,175 20,625
5 12,175 7,025 6,000 8,525 14,950 16,250 9,525 24,400
6 13,400 6,800 6,200 9,200 11,400 18,075 6,500 27,500
7 11,500 7,300 5,650 8,825 11,550 14,525 9,375 19,725
8 10,825 8,475 5,350 9,875 10,075 10,950 8,500 18,275
(Contd.)
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Egg Hatch Assay
Percentage of eggs Hatched
0 98.5 96.6 96.0 98.0 98.2 97.1 98.5 98.2
2 96.0 95.0 97.2 91.2 91.7 99.2 97.2 90.0
4 98.7 96.2 97.5 96.0 92.0 98.5 99.0 97.0
6 99.0 93.4 99.0 97.4 100.0 98.0 99.0 99.0
8 99.1 96.7 98.2 85.4 97.4 95.5 99.1 98.0
Number of Surviving Worms after Treatment
(Mean + Standard Deviation)
44.33 45.66 40.66 37.16 44.33 40.33 36.66 47.83
+ 8.43 +20.32 +21.66 +4.52 +17.22 +11.30 +7.43+14.55
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Table - 5.11
QB Female mice infected with Nematospiroides dubius and 
treated with DPPD, Vitamin E., and Levamisole
on its own or in combination 
Number of eggs produced per gram of faeces
Treatment Groups
Ljay
NONE Vit.E Lev. DPPD Vit.E+ 
DPPD
Lev.+
DPPD
Vit.E+ 
Lev.
Vit. E+Le\ 
DPPD
0 7,850 7,425 8,150 8,275 8,550 9,850 8,175 7,925
l 8,425 9,550 8,625 9,475 11,275 6,850 6,100 5,500
2 8,300 8,150 6,775 11,425 9,450 5,900 5,300 6,350
3 7,650 6,775 5,700 11,250 7,150 7,825 7,550 7,575
4 7,750 4,850 6,025 8,975 8,250 6,975 6,175 6,515
5 8,850 4,100 6,300 6,525 9,125 7,025 7,750 5,050
6 6,500 4,475 5,350 8,375 10,000 7,100 8,150 8,900
7 8,800 4,575 7,250 6,675 13,000 8,225 6,075 7,075
Egg Hatch Assay
Percentage of Eggs Hatched
0 97.8 99.0 97.3 98.0 97.8 98.4 98.2 98.0
2 97.5 99.2 99.2 96.8 99.3 97.5 97.6 97.8
4 99.5 99.2 99.1 99.3 98.2 98.7 98.5 99.2
6 97.8 97.5 98.8 96.7 98.0 99.4 98.5 99.2
Number of Surviving Worms Recovered (Mean + S.D. )
21.4+ 27.8+ 31.5+ 27.0+ 20.3+ 24.6+ 28.0+ 30.3+
4.7 5.5 9.8 4.1 6.7 5.6 7.8 13.2
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Table - 6.1
Tetrathyridia of Mesocestoides corti recovered from the 
peritoneal cavities and livers of QB male mice following 
treatment with Mebendazole, vitamin E, BHA and 
Levamisole on its own or in combination
Treatment Groups
Number of parasites recovered
Peritoneal
Cavities
Livers Total
Mean Standard 
Error
Mean Standard
Error
Mean Standard 
Error
Control 82.50 6.12 65.17 2.98 147.66 6.38
Vitamin E 93.30 6.12 66.00 6.43 178.60 9.82
BHA 85.00 4.40 83.17 11.62 150.20 6.50
Levamisole 91.99 4.82 65.80 4.91 164.40 6.17
Mebendazole 18.33 4.03 4.67 1.91 23.00 5.66
Mebendazole+Vit.E 23.33 5.72 16.14 1.77 39.42 6.66
Mebendazole+Lev. 5.14 2.83 0.29 3.92 5.28 2.80
Mebendazole+BHA 12.00 4.87 8.71 4.49 20.71 8.58
Mebendazole+BHA+
Vit.E
15.85 6.44 17.43 4.50 1.42 0.57
Mebendazole+Lev+
Vit.E
1.00 0.53 0.43 0.43 10.42 5.43
Mebendazole+Vit.E 
+Lev+BHA
5.71 2.34 4.71 3.90 33.28 7.20
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Table - 6»2
Tetrathyridia of Mesocestoides corti recovered from peritoneal 
cavities and livers of CBA male mice following treatment with 
Mebendazole, Vitamin E, Levamisole and BHA
on its own or in combination
Number of parasites recovered
Treatment Groups
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Controls 9 5 . 2 0 1 0 . 2 4 4 8 . 2 0 7 . 7 4 1 4 4 . 0 0 1 3 . 3 7
Vitamin E 1 0 4 . 2 0 6 . 7 9 7 0 . 6 0 7 . 6 0 1 7 4 . 8 0 1 1 . 7 5
BHA 9 7 . 0 0 4 . 5 5 6 7 . 8 0 2 5 . 1 2 1 6 4 . 8 0 2 9 .  oe
Levamisole 9 2 . 2 0 7 . 8 4 5 9 . 0 0 1 3 . 2 5 1 5 1 . 2 0 8 . 6 S
Mebendazole 2 5 . 4 0 2 . 1 4 4 . 6 0 1 . 9 6 3 0 . 0 0 3 . 7 S
Mebendazole+Vit.E 4 1 . 3 0 9 . 6 3 9 . 3 0 6 . 9 4 5 0 . 6 6 1 2 . 0 7
Mebendazole+Lev. 1 7 . 8 0 7 . 4 8 3 . 0 0 1 . 5 4 2 0 . 8 3 7 . 9 2
Mebendazole+BHA 2 4 . 4 0 6 . 6 1 7 . 8 0 2 . 8 7 3 2 . 2 0 9 . 2 7
Mebendazole+BHA+
Vit.E
3 0 . 2 0 9 . 1 0 9 . 0 0 3 . 2 9 6 3 . 8 0 1 0 . 7C
Mebendazole+Lev.+ 
Vit.E
5 5 . 2 0 9 . 4 7 8 . 6 0 3 . 3 6 3 9 . 8 0 2 2 . 8 4
Mebendazole+Vit.E+ 
BHA+Levamisole
1 2 . 2 0 6 . 7 7 1 6 . 2 0 2 . 2 4 3 9 . 2 0 1 2 . 2 ]
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Table - 6.3
Tetrathyridia of Mesocestoides corti recovered from peritoneal 
cavities and livers of QB male mice following treatment with 
Mebendazole, Vitamin E, DPPD and Levamisole 
on its own or in combination
Number of parasites recovered
Treatment Groups ---------------- - ------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard 
Error Error Error
Controls 96.60 8.53 81.00 2.06 181.00 6.50
Vitamin E 98.60 2.29 194.80 0.60 194.80 16.20
Levamisole 102.20 11.34 207.00 0.16 207.00 12.90
DPPD 101.80 8.24 222.20 0.42 222.20 14.90
Mebendazole 10.40 11.44 0.60 6.39 11.00 3.00
Mebendazole+Vit.E 9.40 2.84 1.40 0.40 10.80 3.10
Mebendazole+Lev. 0.80 0.49 0.20 0.20 1.00 0.57
Mebendazole+DPPD 8.90 1.14 0.80 0.20 2.20 0.60
Mebendazole+DPPD+ 9.00 1.05 0.80 0.20 2.20 0.50
Vit.E
Mebendazole+Lev.+ 8.40 3.30 2.00 0.20 18.40 5.60
Vit.E
Mebendazole+Lev.+ 0.20
Vit.E + DPPD.
0.20 0.60 0.60 0.60 0.50
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Table - 6.4
Tetrathyridia of Mesocestoides corti recovered from the 
peritoneal cavities and livers of CBA male mice following 
treatment with Mebendazole, Vitamin E, DPPD and 
Levamisole on its own or in combination 
Number of parasites recovered
Treatment Groups ----------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Control 85.00 10.40 119.20 20.79 204.20 29.20
Vitamin E 88.40 2.91 148.20 1.20 230.60 29.50
Levamisole 102.60 11.31 175.40 34.78 178.00 12.70
DPPD 120.60 7.65 102.40 5.49 222.00 6.60
Mebendazole 8.60 9.47 0.20 7.10 8.80 3.00
Mebendazole+Vit.EI 22.40 2.29 6.20 2.44 28.60 3.10
Mebendazole+Lev. 21.40 2.36 6.50 4.47 27.50 5.10
Mebendazole+DPPD 25.20 2.92 4.80 0.66 29.20 2.90
Mebendazole+DPPD
+Vit.E
21.80 4.39 10.80 3.22 28.80 5.20
Mebendazole+Lev. 19.00 3.24 7.33 1.59 24.67 4.20
Mebendazole+Lev+ 
+ DPPD + Vit.E
8.00 3.70 3.80 1.45 11.80 3.50
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Table - 6,5
Tetrathyridia recovered from peritoneal cavities and livers of 
QB male mice following treatment with Mebendazole and/or
levamisole.
Number of parasites recovered
Treatment groups --------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standaed 
Error Error Error
Control 126.40 9.74 101.80 4.50 233.50 8.41
Levamisole 117.85 4.25 98.43 11.50 206.25 14.64
Mebendazole 10.40 2.30 0.60 0.60 11.00 2.50
Mebendazole + 
Levamisole
0.80 0.50 0.20 0.20 1.00 0.61
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Table - 6.6
Tetrathyredia recovered from peritoneal cavities and livers of 
CBA male mice, following treatment with mebendazole and/or
levamisole
Number of parasites recovered
Treatment groups-------------------- *---------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Control 121.50 36.20 108.80 32.50 130.30 28.40
Levamisole 164.00 9.30 164.00 8.60 249.80 9.50
Mebendazole 8.60 3.55 0.20 0.15 8.80 4.50
Mebendazole + 
Levamisole
22.40 1.80 6.20 2.10 28.60 3.30
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Table -6.7
Tetrathyridia recovered from peritoneal cavities and livers of 
male Swiss white mice following treatment with mebendazole
and/or levamisole
Treatment groups
Number of parasites recovered
Peritoneal Liver Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Control 159.80 10.88 219.20 35.80 379.00 41.10
Levamisole 177.40 14.54 237.40 22.34 414.80 32.11
Mebendazole 3.00 0.77 1.80 0.62 4.80 0.65
Mebendazole + 
Levamisole
2.00 0.77 0.66 0.75 2.66 0.73
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Table - 6.8
Tetrathyridia recovered from peritoneal cavities and livers of 
C57 male mice following treatment with mebendazole and/or
levamisole
Number of parasites recovered
Treatment Groups ------------------------------------------
Peritoneal Livers Total
Cavities
Mean Standard Mean Standard Mean Standard 
Error Error Error
Control 101.80 8.48 86.60 3.50 188.40 7.00
Levamisole 99.40 4.66 109.20 4.15 208.60 8.95
Mebendazole 6.00 1.90 0.20 0.22 6.20 1.80
Mebendazole + 
Levamisole
7.80 3.34 0.80 0.30 8.60 3.00
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Table - 6.9
Tetrathyridia recovered from peritoneal cavities and livers of 
BalbC male mice following treatment with mebendazole and/or
levamisole
Number of parasites recovered
Treatment Groups -----------------------------------------
Peritoneal Livers Total
cavities
Mean Standard Mean Standard Mean Standard
Error Error Error
Control 134.00 12.30 150.20 11.20 264.20 24.20
Levamisole 145.60 11.26 154.00 7.20 279.60 14.25
Mebendazole 6.20 2.31 0.20 0.22 6.40 2.30
Mebendazole + 
Levamisole
6.00 2.38 0.20 0.22 6.16 2.35
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Table - 6.10
Food intake of mice infected with tetrathyridia of Mesoces 
toides corti following treatment with Mebendazole and/or 
levamisole, compared to untreated mice
QB male mice
Treatment Group Food intake/Mouse/Day Mean food
----------------------------------  consumed/
Day-1 Day-2 Day-3 Day-4 Day-5 day + S . D
Control 3.5 3.7 5.1 4.4 3.2 3.98 + 0.25
Mebendazole 3.8 5.8 4.5 3.5 5.9 4.70 + 0.99
Levamisole 4.1 4.3 3.0 5.1 3.8 4.06 + 0.52
Mebendazole* 
levamisole 
Swiss White male
3.5
mice:
3.8 3.9 4.2 5.8 4.24 +0.81
Control 3.7 5.3 3.4 5.2 4.1 4.34 + 0.77
Mebendazole 4.8 4.0 3.6 4.0 4.2 4.12 + 0.39
Levamisole 3.0 4.4 3.5 4.2 3.5 3.52 + 0.38
Mebendazole* 
levamisole 
BalbC male mice:
4.1 3.5 4.4 5.2 3.9 4.22 + 0.57
Control 3.7 4.1 3.8 3.6 3.3 3.50 + 0.47
Mebendazole 3.0 4.1 4.2 3.0 3.1 3.48 + 0.54
Levamisole 4.8 3.2 4.7 3.4 3.0 3.42 + 0.49
Mebendazole*
levamisole
3.9 4.1 4.9 4.6 5.0 4.10 + 0.71
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(Contd.)
C57 male mice:
Control o•in 4.6 5.5 3.2 4.1 4.48 + 0.78
Mebendazole 4.8 3.1 4.0 4.2 3.7 3.96 + 0.56
Levamisole 4.8 4.4 4.0 3.1 5.2 4.30 + 0.72
Mebendazole+ 
levamisole 
CBA male mice:
5.6 5.1 4.1 3.5 4.9 4.64 + 0.74
Control 3.6 3.1 3.9 5.5 4.0 3.65 + 0.35
Mebendazole 3.7 3.9 4.2 3.0 4.7 3.90 + 0.56
Levamisole 4.1 4.0 3.2 3.9 4.8 4.00 + 0.50
Mebendazole+
levamisole
3.9 5.2 4.1 3.6 3.4 4.04 + 0.62
193
Table - 6.11
Liquid intake of mice infected with Mesocestoides corti 
and treated with levamisole and/or mebendazole 
compared to untreated mice
Liquid intake/Mouse/Day (mis) 
Treatment group ----------------------------
Day 1 Day 2 Day 3 Day 4 Day 5
QB male mice:
Control 5.2 5.4 6.0 5.2 5.2
Levamisole 5.7 5.4 5.3 4.8 5.1
Lev.+mebendazole 4.9 5.6 4.7 5.3 4.8
Swiss White mice:
Control 5.6 4.7 5.0 5.2 5.2
Levamisole 5.3 5.1 4.6 4.8 5.0
Lev.+mebendazole 4.8 4.9 5.0 5.2 5.2
BalbC male mice:
Control 5.0 5.3 5.5 5.1 5.5
Levamisole 5.1 5.9 6.0 5.2 5.9
Lev.+mebenda z ole 5.2 5.0 4.9 4.8 5.0
C57 male mice:
Control 6.2 5.7 5.2 6.0 5.9
Levamisole 5.7 6.1 6.2 5.9 5.6
Lev.+mebendazole 4.7 5.8 6.0 5.8 6.0
CBA male mice:
Control 5.6 6.1 5.4 5.7 6.0
Levamisole 4.6 5.2 5.2 5.1 5.2
Lev.+mebendazole 5.2 4.9 5.0 4.7 6.3
Mean water 
consumed/ 
day + S.D.
5.40 +0.30 
5.26 +0.30
5.06 +0.33
5.14 +0.29
4.90 +0.24 
5.02 +0.16
5.28 +0.20 
5.62 +0.38 
4.98 +0.13
5.80 +0.34
5.90 +0.22 
5.66 +0.48
5.76 +0.25
5.06 +0.23 
5.22 +0.56
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Table - 6.12
QB Female mice infected with Nematospiroldes Dubius and treated 
with Mebendazole, Levamisole, BHA and Vit.E on its own or in
combination
Average Number of eggs produced per gram of 
faeces
Treatment Day-0 Day-1 Day-2 Day-3 Day-4 Day-5 Day-6
Group
NONE 8,600 6,700 9,850 8,975 8,120 7,350 7,675
Vitamin E 7,890 5,850 6,750 7,850 7,650 7,100 6,675
Levamisole 7,200 5,025 5,950 6,010 6,185 7,975 8,775
BHA 10,325 9,725 7,250 9,750 12,550 15,825 15,950
Mebendazole 9,450 4,400 3,850 1,540 970 550 0
MBZ + BHA 10,520 9,325 6,325 7,250 8,550 9,350 5,800
MBZ + Lev. 7,570 1,050 250 150 75 0 0
MBZ + Vit.E 8,425 3,025 1,650 250 175 100 0
MBZ+Lev+Vit.E 9,250 850 75 0 0 0 0
MBZ+Vit.E+BHA 8,470 8,025 5,800 6,520 5,250 4,675 350
MBZ+Vit.E+BHA 
+Levamisole
9,430 4,175 1,475 753 550 350 850
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Egg Hatch Assay 
Percentage of Eggs Hatched
Treatment Group Day-0 Day-1 Day-3 Day-5\ No.of Surviving 
Worms recovered 
(Mean+S.D.)
None 98.2 97.8 98.8 95.5 33.0+13.51
Vitamin E 96.5 92.4 95.6 98.0 34.0+ 7.25
Levamisole 99.0 83.9 97.5 86.7 36.0+ 6.91
BHA 98.5 94. 88.5 83.7 33.7+ 4.83
Mebendazole 98.2 2.5 0 0 0
Mebendazole+Lev. 99.0 0 0 0 0
Mebendazole+BHA 99.5 64.9 68.9 80.8 35.5+ 9.57
Mebendazole+Vit.E 98.5 0 0 0 0
MBZ+Lev+Vitamin E 98.2 0 0 0 0
MBZ+Vit.E+BHA 98.6 36.8 19.2 8.8 16.1+ 9.3
MBz+Vit.E+BHA+Lev. 99.0 60.8 7.8 0 8.5+ 7.9
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Table - 6.13
QB Female mice infected with Nematospiroides dubius and treated 
with Mebendazole, Vit.E., Levamisole and DPPD 
on its own or in combination 
Number of Eggs produced per gram of faeces
Treatment Day-0 Day-1 Day-2 Day-3 Day-4 Day-5
Group
None 9,000 10,200 9,650 8,950 8,375 9,560
Mebendazole 17,900 6,750 1,225 1,250 1,575 0
Levamisole 13,650 8,650 8,850 7,825 9,975 10,250
Vitamin E 15,250 15,925 17,750 19,250 20,225 18,750
D.P.P.D 16,900 24,350 8,875 9,275 8,950 8,875
MBZ + Vit.E 13,425 3,175 475 175 100 0
MBZ + DPPD 15,825 6,825 3,250 475 150 0
MBZ + Lev. 13,275 2,700 175 100 0 0
MBZ + DPPD+Vit.E 10,600 6,875 1,475 750 275 0
MBZ + Lev + Vit.E 11,450 1,500 150 0 0 0
Mbz+Lev+DPPD+ 
Vit. E
10,850 12,875 3,150 1,025 0 0
(Contd.)
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Egg Hatch Assay 
Percentage of Eggs Hatched
Treatment Group Day-0 Day-1
v.
Day-3 Surviving worms reco­
vered after Treatment 
(Mean + S.D.)
None 97.5 93.2 95.3 42.0 + 8.14
Mebendazole 99.5 3.8 0 0
Levamisole 94.2 87.4 92.1 39.1 + 9.15
Vitamin E 96.2 94.4 95.8 36.7 + 8.69
DPPD 98.0 92.4 95.5 35.2 + 8.53
MBZ + Vit.E 95.2 0 0 0
MBZ + DPPD 98.0 1.3 0 0
MBZ + Lev 97.5 0 0 0
MBZ + Vit.E + DPPD 97.5 1.6 0 0
MBZ + Lev. + Vit.E 96.0 0 0 0
MBZ + Lev + DPPD + 
Vit.E
95.2 7.6 0 0
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